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Measles virus (MV) belongs to the morbillivirus genus within the 
Paramyxoviridae family of the order Mononegavirales. The order Mononegavirales, 
possess a non-segmented negative-strand RNA genome, includes many important 
animal and human pathogens such as Newcastle disease virus (NDV), rabies virus, 
Nipah virus (NiV), Hendra virus (HeV), mumps virus, human respiratory syncytial 
virus, Marburg virus, and Ebola virus. Some of these viruses are causative agents of 
emerging or re-emerging infectious diseases, and remain serious and persistent public 
health threats. The Paramyxoviridae family includes some important zoonotic agents, 
for instance, NiV, HeV, and NDV. Serological surveys revealed that NiV has a wide host 
range including humans, pigs, dogs, cats, horses, goats, hamsters, and fruit bats (Chua, 
et al., 2003; Mohd, et al., 2000; Harcourt, et al., 2000). HeV is also emerging fatal 
zoonotic agent (Wang, et al., 2001). NDV is an economically important pathogen, 
causing fatal disease in many wild and domestic avian species. The Paramyxoviridae 
family also contains important animal pathogens such as rinderpest virus (RPV) and 
canine distemper virus (CDV), which are classified within the Morbillivirus genus, and 
thus close relatives of MV. Although animals that are susceptible to CDV infection had 
been thought to be the family Canidae, the first natural infection of CDV in a Japanese 
monkey (Macaca fuscata) was reported in 1989 (Yoshikawa, 1989). Furthermore, in 
1990s, CDV infection in tigers, lions, and seals were reported one after another 
(Roelke-Paker et al., 1996; Appel et al., 1994; Osterhaus et al., 1989). Thus, several 
paramyxoviruses are known to infect a wide host range and sometimes cause significant 
cross-species transmission. 
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MV, the causing agent of measles, is a highly contagious human pathogen, 
which is characterized by fever, cough, coryza, conjunctivitis, and a maculopapular rash. 
MV is well known to suppress host immune responses by various mechanisms (de Vries, 
et al, 2012), and therefore measles patients often suffer from symptoms of secondary 
bacterial infections such as diarrhea and pneumonia. The main cause of measles deaths 
is typically secondary infections in respiratory and digestive tract (Shanks, et al., 2011; 
Akramuzzaman, et al., 2000; Beckford, et al., 1985). In the early 1960s, measles was a 
serious worldwide threat because there was no available vaccine, and it is estimated that 
measles caused as many as 6 million deaths per year (Hussey and Clements, 2004). 
However, after an attenuated measles vaccine derived from Edmonston strain was first 
licensed in 1963 (MacLeod, 1964), the number of measles cases reported globally has 
decreased dramatically. The World Health Organization (WHO) has reported that the 
number of estimated measles deaths during 2000 to 2011 decreased 71 percent, from 
548,000 to 158,000 [Centers for Disease Control and Prevention (CDC), 2013]. 
Although the widespread use of effective vaccines has decreased global morbidity and 
mortality from measles, it remains a major cause of high mortality among children in 
developing countries (Bryce, et al., 2005; Wolfson, et al., 2007; CDC, 2008). CDV has 
almost the same historical background as MV. Live-attenuated CDV vaccines became 
available in the 1950s (Rockborn, 1959), which have contributed to the protection of 
domestic dogs against fatal infection with CDV. In recent years, however, sporadic 
outbreaks of CDV and MV become an issue of public health (Gemma, et al., 1996; 
Takahashi, et al., 2014). MV is a well-studied virus and shares many common 
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pathogenic features with other morbilliviruses such as CDV and RPV. Therefore 
findings in fundamental research of MV would be also helpful in understanding the 
pathological mechanism of CDV and RPV, which are one of the most important animal 
pathogens in the field of veterinary medicine. 
MV has a non-segmented negative-stranded RNA genome containing six 
structural genes encoding nucleoprotein (N), phosphoprotein (P), matrix protein (M), 
fusion protein (F), hemagglutinin protein (H), and large protein (L) (Dowling PC, et al., 
1986), and the P gene produces two accessory proteins, known as V and C (Cattaneo, et 
al., 1989; Bellini, et al., 1985). N proteins encapsidate viral genomic RNA to support 
viral transcription and replication by an RNA-dependent RNA polymerase L protein. 
The P protein is a multi-functional protein (Gely, et al., 2010; Sugai, et al., 2008; Karlin, 
et al., 2003) that assists viral transcription and replication as a cofactor of the L protein 
(Cevik, et al., 2004; Curran, 1996). The C and V accessory proteins suppress host 
immune responses (Ramachandran, et al., 2008; Shaffer, et al., 2003). The M protein 
helps virus assembly, and the F protein mediates membrane fusion, virus entry, and 
syncytia formation. The H protein is required for binding to the host cellular receptor 
(Hashiguchi, et al., 2011). Vaccine and laboratory-passaged strains of MV, such as 
Edmonston strain, has adapted to use human CD46 molecule (also known as membrane 
cofactor protein: this antigen is ubiquitously expressed on all nucleated cells) as a 
cellular receptor (Dörig, et al., 1994), while clinical isolates of MV cannot use CD46 
(Dhiman, et al., 2004). Wild type MV strains are known to use SLAM (signaling 
lymphocyte-activation molecule: a glycoprotein expressed on activated lymphocytes 
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and antigen presenting cells) (Yanagi, et al., 2009; Dhiman, et al., 2004; Howie, et al., 
2002) and nectin-4 (expressed on the basal side of polarized epithelial cells) 
(Pratakpiriya, et al., 2012; Noyce, et al., 2011; Mühlebach, et al., 2011; Reymond, et al., 
2001). Both vaccine and clinical isolate strains infect lymphocytes and airway epithelial 
cells through the SLAM and nectin-4, respectively (Delpeut, et al., 2014; Noyce and 
Richardson, 2012; Tatsuo, et al., 2000). 
N protein is the most abundant viral protein in infected cells (Ray and 
Fujinami, 1987), and is mainly required for viral transcription and replication. N 
proteins tightly associate with the viral genome and antigenome to form an N-RNA 
complex with a herringbone-like structure (Bhella, et al., 2004; Lund, et al., 1984). N 
proteins associate with every six bases of the 15,894 nucleotide viral genome and fully 
cover the genome RNA (Calain and Roux, 1993). This tight encapsidation allows the 
viral genome to be resistant to RNases and siRNAs (Bitko and Barik, 2001; Moyer, et 
al., 1990). Viral transcription and replication occur on the N-RNA complex in 
association with viral RNA-dependent RNA polymerase (vRdRp), composed of L and P 
proteins. This complex of N-RNA, P, and L is called the nucleocapsid (NC) and 
comprises 2,649 copies of N, about 300 copies of P, and about 20–30 copies of L (Rima 
and Duprex, 2009; Plumet, et al., 2005; Plumet, et al., 2005 #2). Singly-expressed N 
proteins associate with cellar RNA to form NC-like structures through nonspecific 
association (Warnes, et al., 1995; Fooks, et al., 1993; Spehner, et al., 1991). First, 
vRdRp transcribes the RNA genome and viral structural genes are expressed. When 
sufficient quantity of N proteins has accumulated, the function of vRdRp shifts from 
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transcription to replication, and the RNA genome is replicated exponentially (Plumet, et 
al., 2005). During the replication step, nascent growing viral RNA is immediately 
encapsidated by N protein, and vRdRp ignores gene start (GS) and gene end (GE) 
signals. Thus, uncapped full-length viral antigenomic RNA (positive-sense strand) is 
produced, which serves as a template for viral genome RNA (negative-sense strand) 
replication (Kolakofsky, et al., 2004). 
MV N and P proteins have been known to be constitutively phosphorylated 
(Das, et al., 1995; Robbins, et al., 1980). Phosphorylation is the most general and 
important post-translational modification of proteins as a regulatory mechanism of the 
protein function. Phosphorylation modifications are deeply concerned with various 
intracellular events, such as protein-protein interactions, protein degradation, and 
cellular signal transduction, by altering protein function, conformation, and electrical 
charge (Sugai, et al., 2014; Kitchen, et al., 2008; Weston and Davis, 2007). 
Phosphorylation analyses for MV structural proteins were first reported in the late 
1970s (Robbins, et al., 1980; Robbins and Bussell, 1979; Wechsler and Fields, 1978), 
and these researches demonstrated that N and P proteins of MV were phosphorylated. 
The phosphorylated amino acid species in the N protein were both the serine and 
threonine residues, while phosphorylation at only serine residue was detected within the 
P protein (Gombart, et al., 1995; Robbins, et al., 1980). Furthermore, during the 
mid-1990s, it has been also reported that some serine residues within the N-terminal 
half of the P protein involved in the phosphorylation reaction which was mediated by 
casein kinase II (Das, et al., 1995). Thus, phosphorylation modifications of MV 
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structural proteins have known for more than 40 years. However, no investigation for 
the functional significance of these phosphorylation modifications has been conducted 
until comparatively recent years. 
As the name suggests, the P protein is generally phosphorylated. From 
researches of the P proteins in the related viruses to MV, it has been revealed that the 
phosphorylation of the P protein takes part in the regulation of viral gene expression. 
However, effect of the P protein phosphorylation has been shown to be different by each 
virus; CDV, RPV, and hRSV upregulated its own viral gene expression activity through 
phosphorylation of the P protein (Saikia, et al. 2008; Kaushik and Shaila, 2004; Liu, et 
al., 1997; Barik, et al., 1995), whereas PIV5 and BDV showed downregulation of the 
activity when P protein was phosphorylated (Schmid, et al., 2010; Sun, et al., 2009; 
Timani, et al., 2008). In the case of MV, it has not been clarified whether the 
phosphorylation of P protein is involved in the viral transcription and replication, as 
with other related viruses. Additionally, there is no investigation on relationship 
between phosphorylation of N and P protein. 
In our previous research, it has been demonstrated that phosphorylation sites 
of the MV N protein were the serine residues at location 479 and 510 by mass 
spectrometry, and the phosphorylation was involved in the regulation of transcription 
and/or replication in the context of minigenome assay (Hagiwara, et al., 2008). These 
serine residues at location 479 and 510 are conserved among almost all of MV strain, 
suggesting that these phosphorylation sites are biologically significant during the viral 
life cycle. 
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Hence, in this study, to clarify the functional significance of the 
phosphorylation of MV N and P protein, the author conducted detailed investigation of 
the N and P protein phosphorylation. 
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INTRODUCTION 
 
In CHAPTER 1, the author examined the phosphorylation status of MV N and 
P protein during transcription and replication, and reported the relevance of the N and P 
protein phosphorylation to viral gene expression. 
MV P protein is a cofactor of the viral RNA polymerase (L protein) that 
associates with the nucleoprotein-RNA complex to support viral transcription and 
replication (Rima and Duprex, 2009). In Mononegavirales, P protein undergoes 
phosphorylation (Das, et al., 1995; Robbins, et al., 1980; Robbins and Bussell, 1979; 
Wechsler and Fields, 1978), and many recent reports have highlighted a relationship 
between phosphorylation of P protein and viral gene expression (Sun, et al., 2009; 
Saikia, et al., 2008; Schmid, et al., 2007; Kaushik and Shaila, 2004; Huntley, et al., 
1997; Liu, et al., 1997; Barik, et al., 1995; De, et al., 1995; Gao and Lenard, 1995; 
Huntley, et al., 1995). N protein is also known to be phosphorylated (Gombart, et al., 
1995; Robbins, et al., 1980; Robbins and Bussell, 1979; Wechsler and Fields, 1978). 
Our recent research identified the major phosphorylation sites of MV N protein at S479 
and S510 (Hagiwara, et al., 2008). Alanine-substitution of these phosphorylation sites 
of N protein caused decrease in viral gene expression at virus minigenome experiment, 
suggesting that phosphorylation of N protein takes part in the viral transcription and/or 
replication. Thus, phosphorylation of both N and P proteins are thought to be important 
for viral gene expression. But detail of relationship between N protein phosphorylation 
and viral RNA transcription/replication is not clarified, and there was no research 
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demonstrating relevance between phosphorylation of P protein and viral 
transcription/replication activity in MV. 
To further elucidate the mechanism of viral gene transcription and replication, 
clarification of the roles of N and P protein phosphorylation are needed. In present study, 
the author focused on the relationship between viral transcription/replication activity 
and phosphorylation of P protein, because our resent study suggested mutation of N 
phosphorylation sites raises P protein phosphorylation, and statistically significant 
inverse correlation has found between P phosphorylation and viral gene expression 
activity. Here, the author reports that N protein phosphorylation could influence the 
phosphorylation status of P protein, and the phosphorylation of P protein is involved in 
regulation of viral transcription through changes in its phosphorylation status. 
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MATERIALS AND METHODS 
 
Cells and antibodies 
HEK (human embryonic kidney) 293 and COS-7 (SV40 transformed African green 
monkey kidney fibroblast) cells (Gluzman, 1981) were propagated in Dulbecco’s 
modified Eagle’s medium (Sigma) supplemented with 5% fetal bovine serum (JRH 
Bioscience), 2 mM L-glutamine, 100 U/ml penicillin, and 0.1mg/ml streptomycin at 
37ºC in 5% CO2. Anti-MV N polyclonal antibody was prepared as described previously 
(Hagiwara, et al., 2008). 
 
Plasmids 
The construction of the pCAGGS mammalian expression vectors (Niwa, et al., 1991) 
containing N, N mutants (S479A, E480A, G509A, S510A, D511A, and S479A/S510A), 
P, P mutants (S86A/S151A and T49A/S86A/S151A), and L genes from MV-HL strain 
(Kobune, et al., 1996) was as described (Hagiwara, et al., 2008). In this study, the 
expression plasmid of P protein was modified to not express C protein, which is an 
accessory protein encoded in the P protein gene. 
 
In vitro transcription of minigenomic RNA 
pMDB1 vector (Baron and Barrett, 1997) containing the firefly luciferase gene 
possessing the leader and trailer sequence of the MV-HL strain (1-107 leader and 
15786-15894 trailer nucleotides) (Hagiwara, et al., 2008) was used for in vitro 
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transcription with RiboMAx Large Scale RNA Production System (Promega) according 
to the manufacturer’s instructions. RNA products were purified using MicroSpin G25 
columns (Amersham Biosciences) followed by phenol-chloroform extraction. Purified 
minigenomic RNA was concentrated by 2-propanol precipitation and was dissolved into 
small amount of water. 
 
Minigenome assay 
Precise methods for the minigenome assay have been described previously (Hagiwara, 
et al., 2008). Briefly, 293 cells in 24-well plates were transfected with N-, P-, and 
L-protein expression plasmids using Lipofectamine LTX Reagent (Invitrogen) and Plus 
Reagent (Invitrogen), and viral minigenomic RNAs encoding firefly luciferase were 
transfected with Lipofectamine 2000 Reagent (Invitrogen) the following day. After 24 h, 
cells were lysed in Passive Lysis Buffer (Promega), and luciferase activity was 
measured using a PicaGene Luminescent Kit (Tokyo Ink Manufacturing) according to 
the manufacturer’s instructions. Fluorescent intensity was detected by a luminometer 
Mini Lumat LB 9506 (Berthold). 
 
Immunoprecipitation 
COS-7 cells (5 x 105) were transfected with N and P plasmid, and 293 cells (5 x 105) 
were transfected with plasmids for N, P, L, and minigenomic RNA for firefly luciferase 
using the method described above. At 24 h post transfection, 0.38 mCi/ml of 32P 
(phosphorus-32 Radionuclide, PerkinElmer) or 0.06 mCi/ml of 35S (EasyTag EXPRESS 
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Protein Labeling Mix, PerkinElmer) was added to the media, and incubation continued 
at 37°C for 24 h. Cells were harvested and lysed in lysis buffer (0.5mM of EDTA and 
0.5% of TritonX-100 in PBS) supplemented with Protease Inhibitor Cocktail (BD 
Biosciences) and PhosSTOP Phosphatase Inhibitor Cocktail (Roche) for 1 h at 4°C, and 
cell debris was removed by centrifugation. After preclearing the lysate with Protein A 
Sepharose CL-4B (Amersham Biosciences) beads, lysates were incubated with 
protein-A beads and anti-MV N polyclonal antibodies for 16 h at 4°C. Beads were 
collected and washed five times with PBS, and suspended in 2x Laemmli’s SDS sample 
buffer. Component proteins were separated by SDS-PAGE and radioactivity detected 
using phosphorimager FLA-5100 (Fujifilm). Quantitative analyses of bands was 
performed three times and quantified by Image Gauge (Fujifilm). 
 
Quantitative RT-PCR 
293 cells were transfected with plasmids for N, P, L, and minigenome RNA by the 
method described above. Total RNAs were extracted from the cells using ISOGEN 
(NipponGene). Minigenome RNA, Fluc mRNA, and GAPDH mRNA levels in the total 
RNAs were quantified by real-time RT-PCR using PrimeScript Reverse Transcriptase 
(Takara), SYBR Premix Ex Taq (Takara) and Rotor-Gene Q (QIAGEN). 
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RESULTS 
 
1.1. Inverse relationship between phosphorylation intensity of P protein and viral 
gene expression activity 
 
Our previous study demonstrated that alanine substitution at major 
phosphorylation sites of MV-N protein (S479A, S510A, and double mutant 
S479A/S510A) downregulates viral transcription and/or replication in a minigenome 
assay (Hagiwara, et al., 2008). This assay is a widely used method for measuring the 
RNA polymerase activity of the viral transcription/replication complex (N, P, and L 
proteins associated with minigenomic RNA) via expression of a reporter gene with the 
leader and trailer untranslated regions of viral genomic RNA (Baron and Barrett, 1997; 
Brown, et al., 2005). In the previous research, wild type (wt) N, S479A, and S510A 
proteins expressed alone in cultured cells were strongly labeled with 32P, whereas the 
S479A/S510A mutant showed significant reduction in phosphorylation level (Hagiwara, 
et al., 2008). The author used the same method to detect the phosphorylation status of N 
protein during transcription/replication by investigating the phosphorylation level of N 
protein in presence of P, L, and minigenomic RNA. The phosphorylation pattern of N 
protein in the assay was different from when N protein was expressed alone. The 
phosphorylation level of S479A was markedly higher than wt or another N protein 
mutant. S479A/S510A showed a very low level of phosphorylation and wt-N and 
S510A showed a moderate level (Fig. 1A and 1B). However, no significant correlation 
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was found between N protein phosphorylation level and transcription/replication 
activity, under any conditions (Fig. 1E). Interestingly, however, immunoprecipitation 
(IP) demonstrated that the presence of N protein mutants changed the phosphorylation 
status of P protein. P protein that was coprecipitated with wt-N protein showed a low 
phosphorylation level, while P protein coprecipitated with N protein mutants (S479A, 
S510A, and S479A/S510A) was highly phosphorylated (Fig. 1C and 1D). Of note, 
highly phosphorylated P protein corresponded well with abrogation of viral RNA 
expression, and the phosphorylation level of P protein was inversely related to 
transcription/replication activity in the minigenome assay (Fig. 1D and 1E). Taken 
together, these results implied that changes in the phosphorylation status of N protein 
indirectly downregulate the reporter gene expression through altering phosphorylation 
intensity of P protein. 
 
1.2. P protein Phosphorylation is affected by phosphorylation status of N protein 
 
Alanine substitution at major phosphorylation sites of N protein (S479A, 
S510A, and S479A/S510A) promoted P protein phosphorylation via N-P protein 
interaction. To determine whether elevation of P protein phosphorylation was caused by 
changes in the phosphorylation status of N protein or were independent of N protein 
phosphorylation, the author generated additional N protein mutants with alanine 
substitutions at amino acids adjacent to major phosphorylation sites (E480A, G509A, 
and D511A). The author used IP to examine the phosphorylation level of the P protein 
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associated with these N protein mutants. The S479A, S510A, and S479A/S510A 
mutants of N protein increased P protein phosphorylation, while E480A, G509A, and 
D511A mutants of N protein caused no change in the phosphorylation status of P 
protein (Fig. 2A and 2B). Thus, the increase in P protein phosphorylation was 
accompanied by changes in N protein phosphorylation status. These data suggested that 
both S479 and S510 of N protein must be phosphorylated to maintain P protein at its 
basal phosphorylation level, and the absence of a phosphate group at S479 and/or S510 
caused enhancement of P protein phosphorylation and downregulation of viral 
transcription/replication. In other words, phosphorylation of P protein that caused 
downregulation of viral transcription/replication could be induced by modulation of N 
protein phosphorylation. 
 
1.3. Phosphorylation at S86 and/or S151 of P protein is critical for downregulation 
of viral transcription/replication 
 
S86 and S151 of MV-P protein are reported to be sites for phosphorylation by 
casein kinase II (CKII) (Das, et al., 1995). T49 of MV-P protein is homologous to the 
major phosphorylation site of rinderpest virus (RPV) P protein, which is a closely 
related morbillivirus (Saikia, et al., 2008; Kaushik and Shaila, 2004). To further clarify 
the correlation between phosphorylation of P protein and viral transcription/replication 
activity, the author generated mutants of P protein whose phosphorylation sites were 
substituted with alanine residues: S86A/S151A (dP) and T49A/S86A/S151A (tP). IP 
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and minigenome assay were conducted using mutants of N and P protein. IP results 
demonstrated that the phosphorylation levels of dP and tP did not significantly decrease 
compared to wt-P protein associated with wt-N protein (Fig. 3A and 3B). This indicated 
that the substituted sites of dP and tP were not constitutively phosphorylated. In contrast 
to wt-P protein, the phosphorylation levels of dP and tP were not enhanced by 
association with N protein mutants (S479A, S510A, and S479A/S510A) (Fig. 3A and 
3B). This suggested that the elevation in the phosphorylation of P protein was due to 
phosphorylation at S86 and/or S151. Furthermore, comparison of dP and tP showed that 
alanine substitution of T49 did not decrease phosphorylation of P protein. Therefore, 
T49 was not important as a phosphate group acceptor. 
By minigenome assay, the alanine substitutions in the dP and tP mutants did 
not impair the function of P protein as a cofactor of RNA polymerase (Fig. 4A). N 
protein with mutations at major phosphorylation sites downregulated 
transcription/replication in association with wt-P protein, but failed to decrease 
transcription/replication activity in combination with dP or tP (Fig. 4B-D). Hence 
phosphorylation at S86 and/or S151 of P protein was likely to play an important role in 
downregulation of viral transcription/replication. Additionally, since mutations of dP 
(S86 and S151) were sufficient to restore the decreased transcription/replication activity, 
the T49 site of P protein was not necessary for regulation of transcription/replication in 
MV (Fig. 4B-D). Collectively, downregulation of viral transcription/replication in the 
minigenome assay was caused by an elevation in the phosphorylation level of P protein, 
specifically at S86 and/or S151.  
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1.4. Statistical evaluation of correlation between P protein phosphorylation 
intensity and viral transcription/replication activity 
 
To calculate the correlation between the phosphorylation level of MV P protein 
and viral transcription/replication activity, the author quantified the intensity of 
phosphorylation by densitometry. Its correlation with viral transcription/replication 
activity was represented as a coefficient of determination (r2). On scatter diagrams, a 
strong inverse correlation was observed between the phosphorylation level of P protein 
and viral transcription/replication activity, implying that viral transcription/replication 
was affected by the total phosphorylation level of P protein. Furthermore, the best-fit 
curve of the relationship was obtained by exponential approximation (r2 = 0.97) (Fig. 
5A) rather than linear approximation (r2 = 0.78) (Fig. 5B), and an acquired regression 
curve suggested that transcription/replication activity was abruptly attenuated when P 
protein exceeded an optimum phosphorylation level. Therefore, strong phosphorylations 
at 86S and 151S sites were likely to be important for negative regulation of 
transcription/replication. In contrast, N protein phosphorylation intensity had no 
correlation with viral transcription/replication, with a coefficient of determination of 
0.0018 (Fig.  5C). 
 
1.5. Phosphorylation of P protein at S86 and S151 selectively downregulated viral 
transcriptional activity 
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To determine which step in viral RNA synthesis was affected by 
P-phosphorylation, the author measured viral transcription and replication efficiency by 
quantitative RT-PCR under the same condition as minigenome assay. As a result, 
transcription efficiency (mRNA/minigenome) of mutants of N protein (S479A, S510A, 
and S479A/S510A) was significantly reduced from 27.9 to 33.1%, while replication 
efficiency (minigenome) showed no significant differences (Fig. 6A and 6C). Quantities 
of Fluc mRNA corresponded with the pattern of Fluc activity in minigenome assay (Fig. 
1E and 6B). These data suggest that downregulation of viral RNA synthesis 
accompanied with P-phosphorylation at S86 and S151 was caused by decrease in 
transcriptional activity rather than replication. Slight differences in replication 
efficiency were not correlated with phosphorylation level of P protein; therefore these 
differences in replication may not be caused by P phosphorylation. 
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DISCUSSION 
 
The author found that N protein and the mutants S479A, S510A, and S479A/S510A 
showed a different phosphorylation pattern during viral transcription/replication than N 
protein expressed alone in cultured cells. Since N protein coimmunoprecipitated with P 
protein showed different phosphorylation pattern, N-P protein association could change 
the phosphorylation status of N protein. Additionally, N-P association also affected the 
phosphorylation status of P protein. It was revealed that phosphorylation of N protein 
was indirectly involved in the efficiency of viral RNA synthesis in the minigenome 
assay. As shown in Figure 5 and 6, a strong inverse correlation was found between the 
phosphorylation level of P protein and viral transcriptional activity. Phosphorylation of 
P protein has generally believed to be connected with upregulation in viral RNA 
synthesis. For instance, removal or inhibition of kinase activity for P protein decreases 
transcription/replication activity or viral growth in canine distemper virus (Liu, et al., 
1997), sendai virus (Huntley, et al., 1997), human parainfluenza virus type 3 (De, et al., 
1995; Huntley, et al., 1995), and vesicular stomatitis virus (Gao and Lenard, 1995). As 
a more direct approach, site-directed mutagenesis at the phosphorylation site of P 
protein causes a decrease in viral gene expression in rinderpest virus (Saikia, et al., 
2008; Kaushik and Shaila, 2004) and human respiratory syncytial virus (Barik, et al., 
1995). These phosphorylation sites seem to be required for efficient P protein function. 
Recently, however, mutation at the phosphorylation sites of P protein increased viral 
gene expression activity in parainfluenza type 5 (PIV5) (S308) (Sun, et al., 2009; 
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Timani, et al., 2008) and borna disease virus (BDV) (S26, S28) (Schmid, et al., 2007; 
Schmid, et al., 2010). In PIV5, increased viral gene expression causes induction of cell 
death and expression of cytokines such as IFN- and IL-6. Viral gene expression of 
PIV5 is negatively regulated by phosphorylation of P protein, enabling efficient 
avoidance of host immune responses (Sun, et al., 2009). In BDV, negative regulation by 
phosphorylation of P protein has been suggested as a prerequisite for efficient viral 
dissemination (Schmid, et al., 2010). As a common mechanism among 
Mononegavirales, in addition to constitutive phosphorylation sites that are necessary for 
activity, MV-P protein could also possess regulatory phosphorylation sites to maintain a 
transcription level. If MV uses the same strategy as PIV5 and BDV, S86 and S151 
would be strong candidates for regulatory phosphorylation sites in MV-P, and 
phosphorylation of P protein at S86 and/or S151 could serve as negative regulator of 
viral gene expression for efficient viral growth. 
Although the major phosphorylation sites S479 and S510 of N protein are 
adjacent to the binding region for P protein (Bernard, et al., 2009; Houben, et al., 2007; 
Longhi, et al., 2003), mutations caused no impairment in N-P association by IP (Fig. 1A 
and 1C) or complex formation assay (Hagiwara, et al., 2008). Of note, the double 
mutant (S479A/S510A) showed higher activity than either single mutant (S479A, 
S510A) in a minigenome assay (Fig.1E). Furthermore, mutations at contiguous sites of 
N protein phosphorylation sites failed to enhance P protein phosphorylation (Fig. 2). 
These findings suggest that excessive phosphorylation of P protein caused by N protein 
mutants is probably not responsible for a structural abnormality of N protein, but relies 
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on a change in its phosphorylation properties. The findings in this chapter could provide 
a new regulatory mechanism of viral gene expression: phosphorylation at S86 and S151 
of MV-P protein is generally suppressed, and change in the phosphorylation status of N 
protein or direct phosphorylation at S86 and S151 of the P protein, resulting in 
reduction of viral gene expression. Hence, a dephosphorylation system for N protein 
might serve as a switch for P protein activity. 
Phosphorylation status of measles virus N protein has been investigated under 
various conditions since the late 1970s. Some papers reported that no difference was 
found between phosphorylation status of N protein from nucleocapsids or virions in 
acutely infected cells and persistently infected cells (Robbins, et al., 1980; Robbins and 
Bussell, 1979). It was also reported that free N protein and nucleocapsid-associated N 
protein showed different phosphorylation pattern (Gombart, et al., 1995; Kawai, et al., 
1999). However influence of N-P interaction on its own phosphorylation status has not 
been studied. In this report, the author demonstrated that N and P protein changes own 
phosphorylation status through N-P interaction. Thus, the presence of P protein is 
important when considering the changes of N-phosphorylation status, and this finding 
would help the understanding of the past reports of N-phosphorylation. Biological 
significance of the changes in phosphorylation status of N and P protein through the 
viral life cycle is unknown. However, downregulation of transcription via 
phosphorylation at S86 and/or S151 of P protein could be a key step in determining the 
role of N and P protein phosphorylation. 
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FIGURE LEGENDS 
 
Fig. 1 
Correlation between phosphorylation level of P protein and transcription/replication 
activity. 293 cells were transfected with expression plasmids for N, P, L, and 
minigenome RNA, and lysates used for IP and minigenome assay. (A) 32P or 35S-labeled 
N proteins were immunoprecipitated with anti-N protein polyclonal antibodies and 
separated by SDS-PAGE. (B) Phosphorylation levels of N protein were quantified by 
densitometry. (C) 32P or 35S-labeled P protein coprecipitated with N protein was 
detected the same time with N protein. (D) Phosphorylation levels of P protein were 
quantifed. (E) Minigenome assay using a series of N protein mutants. * p < 0.05, ** p < 
0.01. Error bars indicate standard deviations. 
 
Fig. 2  
N protein mutants with alanine substitutions at residues adjacent to major 
phosphorylation sites do not enhance phosphorylation of P protein. (A) P protein 
expressed in COS-7 cells with various N protein mutants (without L protein and 
minigneome RNA), and IP was performed with anti-N polyclonal antibody. (B) 
Densitometry of the bands of P protein coprecipitated with N protein mutants. 
 
Fig. 3 
Phosphorylation levels of dP and tP were not enhanced by association with N protein 
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mutants. (A) Various pair of RI labeled-N and -P protein mutants expressed in 293 cells 
under presence of L protein and minigenome RNA were immunoprecipitated using 
anti-N polyclonal antibody. dP: S86A/S151A, tP: T49A/S86A/S151A. The graphs show 
the densitometry of (B) N and (C) P protein bands. ** p < 0.01 
 
Fig. 4 
Transcription/replication activity was affected by phosphorylation status of P protein 
rather than N protein. Wt-P, dP (S86A/S151A), and tP (T49A/ S86A/S151A) were 
subjected to minigenome assay in pairs with (A) wt-N, (B) N (S479A), (C) N (S510A), 
and (D) N (S479/510A). * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars indicate 
standard deviations. 
 
Fig. 5 
Viral transcription/replication activity was inversely related to the total phosphorylation 
level of P protein in exponential manner. From Figures 3 and 4, relationships between 
the phosphorylation level of P protein and viral transcription/replication activity for 
various pairs of mutants were plotted on scatter diagrams, and significant correlations 
found. Correlation was represented by (A) exponential approximation (r2 = 0.97) rather 
than (B) linear approximation (r2 = 0.78). (C) Phosphorylation of N protein had no 
correlation with transcription/replication (r2 = 0.0018). 
 
Fig. 6 
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Quantitative RT-PCR of minigenome RNAs and its transcripts. Minigenome RNAs and 
its transcripts were detected by quantitative RT-PCR from 293 cells that transfected with 
plasmid for N (wt, S479A, S510A, and S479A/S510A), P, L, and minigenome RNA by 
the same method of minigenome assay. Reverse transcription was performed with 
oligo-dT or minigenome specific primer (GGCCGTCATGGTGGCGAATACCAA 
ACAAAGTTGGGTAAGGATAGATCAATCAATGATC), and following real-time 
PCR was performed with primer pairs for the minigenome (F: 
GGCCGTCATGGTGGCGAAT/R: AGCGTAAGTGATGTCCAC), the transcripts (F: 
GTACACGTTCGTCACATCTC/R: CGCAGGCAGTTCTATGAGGC), and GAPDH 
(F: AACATCATCCCTGCCTCTACTG/R: GCTTCACCACCTTCTTGATGTC). (A) 
minigenome RNA levels (B) Fluc mRNA levels (C) transcription efficiency. * p < 0.05. 
Error bars indicate standard deviations. 
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CHAPTER 2 
 
 
Detailed Investigations for Phosphorylation Sites of  
Measles Virus Nucleoprotein: 
 
Growth kinetic analysis for recombinant viruses containing  
mutation in the nucleoprotein phosphorylation sites 
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INTRODUCTION 
 
MV N protein associates with the viral RNA genome to form the N-RNA complex, 
providing a template for viral RNA synthesis. In our previous study, it has been reported 
that the MV N protein undergoes phosphorylation, and the major phosphorylation sites 
of the MV N protein are S479 and S510 (Hagiwara, et al., 2008). In CHAPTER 1, the 
author also showed that the status of the major phosphorylation sites of the N protein 
affected to the phosphorylation status of the P protein (Sugai, et al., 2012). However, 
the functional significance of these N-phosphorylation sites has not been clarified. 
In this chapter, the author rescued recombinant MV (rMV) HL strains (Kobune, 
et al., 1996) whose phosphorylation sites in the N protein were substituted with alanine 
residues (rMV-S479A, rMV-S510A, and rMV-S479A/S510A) using a reverse genetics 
system that we had previously established (Terao-Muto, et al., 2008), and conducted 
detailed investigation for influence of their phosphorylation on virus growth. 
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MATERIALS AND METHODS 
 
Cells, Viruses, Plasmids, and Antibodies 
B95a cells (Epstein-Barr virus-transformed marmoset B-lymphoblastoid cells) (Kai, et 
al., 1993; Kobune, et al., 1996) were propagated in a RPMI-1640 medium (Sigma) 
supplemented with 5% fetal bovine serum (JRH Bioscience), 2 mM L-glutamine, 
100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37ºC/5% CO2. HEK 293 and 
293SLAM cells (HEK 293 cells stably expressing the signaling lymphocyte activation 
molecule [SLAM], which is a cellular receptor for MV) (Sato, et al., 2008; Tatsuo, et al., 
2000) were maintained in Dulbecco’s modified Eagle’s medium (Sigma) with the same 
supplements described above. The virulent MV-HL strain (Kobune, et al., 1996) and its 
recombinant viruses were propagated and titrated in B95a cells. The generation of the 
pCAGGS mammalian expression vectors (Niwa, et al., 1991) containing wild-type N 
(wt-N), N mutants (S479A, S510A, S479A/S510A, and 74-77A), P, and M genes from 
the MV-HL strain, along with anti-N, -P, and -M polyclonal antibodies, and anti-N 
protein monoclonal antibody 8G were prepared as previously described (Hagiwara, et 
al., 2008; Masuda, et al., 2006). 
 
Rescue of rMVs 
Amplification of the MV N mutant genes (S479A, S510A, and S479A/S510A) was 
conducted by polymerase chain reaction (PCR) using Takara LA Taq (Takara Bio) and 
primers F (5′-CGG CGG CCG CTT CAC GAT GGC CAC ACT TTT GAG G-3′, NotI 
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site underlined) and R (5′-CAG GCC GGC CCT AGT CTA GAA GAT CTC T-3′, FseI 
site underlined). The amplicons were cloned into the pCR2.1 TOPO (TOPO TA 
Cloning Kit, Invitrogen) vector according to the manufacturer’s instructions. The 
resulting plasmids were transformed into Escherichia coli DH5α cells and grown, then 
digested with NotI and FseI (Takara Bio), and fragments inserted between the NotI and 
FseI sites of the MeV-HL full genomic plasmid (7+) (Terao-Muto, et al., 2008) to 
replace the wt-N gene. Rescue of the recombinant viruses was conducted as previously 
reported (Terao-Muto, et al., 2008). Briefly, vaccinia virus-infected HEK 293 cells were 
transfected with N, P, and L protein expression plasmids, and the MV full genome 
plasmid whose N protein was mutated at phosphorylation sites (pMDBI-wt, S479A, 
S510A, and S479A/S510A). B95a cells were added onto transfected HEK 293 cells 
2 days after transfection. When an adequate cytopathic effect was observed, infected 
cells were subjected to three freeze-thaw cycles followed by sonication. After removal 
of cellular debris, recombinant viruses in the supernatant were concentrated by 
centrifugation (25,000 rpm, 2 h, 4ºC) in an Sw28 rotor (Beckman), and the viral pellet 
dissolved in an appropriate volume of phosphate-buffered saline (PBS). Viral titers 
were expressed as the 50% tissue culture infectious dose per milliliter (TCID50/ml), and 
were measured in B95a cells. Reverse transcription (RT) and direct sequencing using 
viral RNA extracted from infected cells of each recombinant virus were conducted to 
ensure that substitutions in the phosphorylation sites were contained in the N protein 
gene of the recombinant viruses. 
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Immunoprecipitation assay 
HEK 293 cells were transfected with plasmids expressing wt-N and N mutants (S479A, 
S510A, S479A/S510A and 74-77A), with or without the P plasmid. At 24 h 
post-transfection, 0.38 mCi/ml 32P (Phosphorus-32 Radionuclide, PerkinElmer) or 
0.06 mCi/ml 35S (EasyTag Express Protein Labeling Mix, PerkinElmer) was added to 
the medium, and incubated at 37°C for 24 h. Cells were harvested and lysed using lysis 
buffer (0.5 mM EDTA, 0.5% TritonX-100 in PBS) supplemented with a Protease 
Inhibitor Cocktail (BD Biosciences) and a PhosSTOP Phosphatase Inhibitor Cocktail 
(Roche Applied Science) for 1 h at 4°C. Cell debris was removed from the lysate by 
centrifugation. Lysates were incubated with Protein A Sepharose CL-4B (Amersham 
Biosciences) and anti-N or -P polyclonal antibodies for 16 h at 4°C. Beads were washed 
five times with PBS, and suspended in 2× Laemmli’s sodium dodecyl sulfate (SDS) 
sample buffer. Proteins were separated by SDS-polyacrylamide gel electrophoresis 
(PAGE), and radioactivity detected using an Imaging Plate and phosphorimager 
FLA-5100 (Fujifilm). Experiments were performed two or three times independently. 
The principle of the Imaging Plate method is as follows: the photostimulable phosphor 
on the Imaging Plate stores radiation energy by the electrical change from the ground 
state to the excited state. The stored excitation energy is converted to 
chemiluminescence by laser scanning of the phosphorimager, and the data are saved in 
a digital format. This detection system enables quantitative analysis of phosphorylation 
within a linear range. 
 5 × 105 293SLAM cells were infected with wild-type or rMV-HL viruses. The 
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author then added 32P (0.38 mCi/ml) and 35S (0.06 mCi/ml) to the medium just after 
infection, and viruses were labeled until infected cells were harvested. At each time 
point from 16 h post-infection (hpi) to 6 days post-infection (dpi), cells were harvested 
and lysed. Following immunoprecipitation, SDS-PAGE and imaging were carried out as 
described above. 
 
One-step and multi-step growth kinetics 
The author infected 293SLAM cells with wt or recombinant viruses at a multiplicity of 
infection (MOI) of 1.0 or 0.001, in duplicate. The infected cells and supernatant were 
harvested at 4, 8, 12, 16, 20, and 24 hpi (MOI = 1.0), or 12, 24, 48, 72, 96, 120, and 
144 hpi (MOI = 0.001), respectively. After three cycles of freeze-thawing and 
sonication of infected cells, lysates were centrifuged to remove cellular debris, and the 
supernatant collected. The titer (TCID50/ml) of each sample was measured using B95a 
cells. 
 
Western blot analysis 
The 293SLAM cells infected with MVs were washed in PBS and lysed in buffer 
(0.5 mM EDTA, 0.5% TritonX-100 in PBS) containing a Protease Inhibitor Cocktail, at 
8, 16, 20, and 24 hpi (MOI = 1.0), and 2, 3, 4, 5, and 6 dpi (MOI = 0.001). The 
HEK 293 cells transfected with expression plasmids using the FuGENE 6 Transfection 
Reagent (Roche Applied Science) were lysed at 48 h post-transfection. Each lysate was 
separated by 8% or 10% SDS-PAGE, and transferred onto an Immobilon-P Transfer 
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Membrane (Millipore). Membranes were blocked with BlockACE (DS Pharma 
Biomedical), then incubated with a primary antibody for 1 h at 37°C. The membrane 
was washed five times with PBS containing 0.05% Tween-20, and incubated with a 
polyclonal rabbit anti-mouse IgG conjugated to horseradish peroxidase (1:2000 
dilution; Dako Cytomation) for 1 h at 37°C. Immunoreactive bands were visualized 
using ECL western blotting detection reagents (GE Healthcare). Detection and scanning 
of chemiluminescence were performed with a luminescent image analyzer 
(LAS-1000UV mini system, Fujifilm). 
 
Measurement of IFN- and RANTES levels 
The 293SLAM cells were infected with wt-MV or rMVs at an MOI of 1.0. Total RNA 
was extracted with ISOGEN (Nippon Gene) at 24 hpi, and RT was conducted with a 1:1 
mixture of oligo-dT primers and random hexamers, and PrimeScript RTase (Takara) 
according to the manufacturer’s instruction. Quantitative PCR (qPCR) assays were 
conducted using IFN--specific (5′-CAG CAG TTC CAG AAG GAG GA-3′ and 
5′-AGC CAG GAG GTT CTC AAC AA-3′) and RANTES-specific (5′-TCA TCC TCA 
TTG CTA CTG CC-3′ and 5′-GGT GAC AAA GAC GAC TGC TG-3′) primers and 
SYBR Premix Ex Taq (Takara). GAPDH was used as an internal control and expression 
levels determined with specific primers (5′-AAC ATC ATC CCT GCC TCT ACT G-3′ 
and 5′-GCT TCA CCA CCT TCT TGA TGT C-3′). All qPCR assays were conducted 
on a Rotor-Gene Q (Qiagen). 
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Indirect immunofluorescence assays 
The HEK 293 cells were transfected with expression vectors for wt-N, N protein 
mutants (S479A, S510A, S479A/S510A and 74-77A), and the P protein using the 
FuGENE 6 Transfection Reagent, according to the manufacturer’s instructions. At 24 h 
post-transfection, cells were fixed with 3% paraformaldehyde in PBS, and 
permeabilized with 0.5% Triton X-100 in PBS. Cells were incubated with an anti-N 
protein polyclonal antibody, followed by incubation with AlexaFluor 488-conjugated 
goat anti-rabbit IgG (1:2000; Invitrogen) supplemented with Hoechst 33342 (Cambrex 
Bio Science). A confocal laser-scanning microscope (Fluoview FV1000-D system; 
Olympus) was used to visualize the fluorescence. 
 
Complex formation assay 
HEK 293 cells were transfected with plasmids expressing wt-N, N mutants, P, or M 
proteins. Cells were lysed at 48 h post-transfection, and the cell lysates of N, P, and M 
protein-transfected cells were mixed and incubated for 1 h at 4°C. N, P, and M protein 
complexes were immunoprecipitated with an anti-N protein monoclonal antibody 8G. 
Co-precipitated N, P, and M proteins were separated by SDS-PAGE and detected by 
immunoblotting using anti-N, -P, and -M protein polyclonal antibodies. 
 
Pulse-chase assay 
The 293SLAM cells infected with wt-MV or N protein rMVs (S479A, S510A, and 
S479A/S510A) at an MOI of 0.01 were labeled with [5,6-3H] uridine (20 Ci/ml, 
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PerkinElmer) for 18 h between 6 and 24 hpi. The culture medium was replaced with 
medium containing excess UTP (200 nM/ml, Roche) and ribavirin (250 ) at 1 dpi to 
stop the incorporation of [5,6-3H] uridine. Infected cells were harvested and lysed at 0, 6, 
24, and 48 h after the medium change. The released viruses were precipitated by 
centrifugation, and lysed with infected cells. The nucleocapsid proteins in the lysate 
were separated by 25–40% sucrose gradient density centrifugation at 55,000 rpm for 1 h 
(Sw55Ti Rotor; Beckman). A Tri-Carb 2100TR Liquid Scintillation Analyzer 
(PerkinElmer) was used to measure radioactivity. 
 
RNase protection assay 
The author infected 293SLAM cells with wt-MV or rMVs (S479A, S510A, and 
S479A/S510A) at an MOI of 0.001. Infected cells were divided into two equal portions 
after 5 days of incubation. One portion was lysed with micrococcal nuclease (MNase) 
buffer (10 mM Tris-HCL pH 7.5, 10 mM NaCl, 5 mM MgCl2, 2 mM CaCl2, 1% Triton 
X-100, 0.5% sodium DOC, BaculoGold Protease Inhibitor Cocktail [BD Biosciences], 
and 100 U/ml DNase) and treated with Trizol LS (Invitrogen) to extract RNA. The other 
portion was lysed with MNase buffer supplemented with 100 U/ml MNase for 1 h at 
37°C, followed by RNA extraction with Trizol LS. From the extracted RNAs, the viral 
genomic RNA was quantified by RT-PCR to calculate the protection rate from MNase. 
The RT reaction was conducted with MV genome RT primer (5′-GGC CGT CAT GGT 
GGC GAA TCC TAC CTC GAC CTG TTG TTG AAT GAA GAG TTA GAA GAG 
TTC AC-3′) and PrimeScript RTase (Takara), according to the manufacturer’s 
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instructions. Subsequently, qPCR assays were conducted with forward (5′-GGC CGT 
CAT GGT GGC GAA T-3′) and reverse (5′-TGT TCC ACG AAG ATC CT-3′) primers 
and SYBR Premix Ex Taq (Takara) on a Rotor-Gene Q. Genomic RNA quantities from 
MNase-treated and untreated samples were compared to calculate the protection rate. 
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RESULTS 
 
2.1. Binding of N protein to P protein alters the phosphorylation pattern of the N 
protein.  
 
In CHAPTER 1, it was suggested that the interaction between the N and P proteins 
affects the N protein phosphorylation status (Sugai, et al., 2012). The author first 
compared the phosphorylation status of wt-N and its phosphorylation site mutants 
(S479A, S510A, and S479A/S510A) in the presence or absence of the P protein 
(without L and minigenome RNA) in HEK293 cells. 32P- or 35S-labeled wt-N and N 
mutants with or without the P protein were immunoprecipitated with anti-N or anti-P 
protein antibodies, respectively. The N protein that was expressed alone showed a 
different phosphorylation pattern to the N protein that bound to the P protein (Fig. 1A 
and B), suggesting that N-P protein interaction affects the phosphorylation status of the 
N protein. To further evaluate these changes, the author rescued recombinant viruses 
whose N protein phosphorylation sites were substituted (rMV-S479A, rMV-S510A, and 
rMV-S479A/S510A) by reverse genetics, and investigated the phosphorylation status of 
the N protein in cells infected with recombinant viruses at 2 dpi. The N protein in the 
rMV-infected 293SLAM cells showed the same phosphorylation pattern as the N 
protein in co-transfected cells (Fig. 1B and C). This implies that N-phosphorylation of 
rMVs in the infected cells was also affected by N-P protein association. 
The N protein expressed alone in cultured cells is imported into the nucleus. 
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However, the presence of the P protein retains the N protein in the cytoplasm (Huber, et 
al., 1991). Therefore, it is unclear whether the changes in N-phosphorylation through 
the N-P interaction depends upon the change in localization, or on the binding of the N 
and P proteins. In our previous report, a nuclear localization signal in the N protein was 
already identified. Thus, the author employed an N protein mutant (74-77A, referred to 
as mN) that localized to the cytoplasm (Sato, et al., 2006) to compare the 
phosphorylation of the wt-N and mN expressed alone or with the P protein. The 
phosphorylation level of the wt-N protein associated with the P protein was 37.4% of 
that for the free wt-N protein in HEK 293 cells (Fig. 2A). The mN protein expressed 
with the P protein also had a reduced phosphorylation level (35.6%) compared with the 
free mN protein (Fig. 2B). This indicates that the N-phosphorylation level was directly 
downregulated by N-P protein binding, and was not affected by the localization of the N 
protein. 
 
2.2 One- and multi-step growth kinetics of rMVs. 
 
To investigate the influence of N-phosphorylation on virus production, the author 
compared one- and multi-step virus growth kinetics of wt-MV and rMVs (S479A, 
S510A and S479A/S510A). Released and cell-associated viruses were harvested at 
4–24 hpi (one-step growth) and 0.5–6 dpi (multi-step growth) and their titers 
determined. In the one-step analysis, rMV-S479A/S510A rapidly replicated and reached 
their peak titer at 20 hpi, while the wt-MV showed slower growth kinetics until 20 hpi. 
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The titer of wt-MV at 24 hpi was the same or slightly higher than that of 
rMV-S479A/S510A. In one-step growth, rMV-S479A and rMV-A510A showed 
moderate replication levels; however, the peak titer for rMV-S479A was the lowest. 
The cell-free rMVs showed similar growth kinetics to the cell-associated viruses (Fig. 
3A and B). Conversely, in multi-step growth kinetics, rMV-S479A/S510A propagated 
most efficiently and showed higher peak titers. These titers remained high during the 
plateau phase of viral growth (around 3–6 dpi). The growth of rMV-S479A was lowest, 
while other viruses showed moderate growth levels (Fig. 3C and D). Although 
rMV-S479A replicated faster than wt-MV in one-step growth kinetics, it could not 
maintain a higher titer than the other viruses during the latter phases of multi-step 
growth. The different characteristics in the early and late phases of growth suggested 
that N-phosphorylation has multiple roles in the virus life cycle. 
To investigate the influences of N-phosphorylation on viral growth, the author 
performed a time course analysis of N gene expression. Recombinant virus-infected 
293SLAM cells were harvested at each time point, and N proteins detected by 
immunoblotting. Accumulation of the N protein, and growth rates were almost similar 
in the one-step and multi-step growth analysis (Fig. 4A and B), suggesting that the 
differences in growth kinetics between wt-MV and rMVs were caused by changes in 
viral gene expression levels. It also suggests that N-phosphorylation is involved in the 
regulation of viral gene expression. It has been reported that transcription of the MV N 
protein induces cytokine expression, such as RANTES, in a dose-dependent manner 
(Noe, et al., 1999); therefore it was also evaluated whether these changes in viral gene 
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expression affected induction of the host immune response. Induction of cytokines was 
significantly lower for wt-MV compared with rMV-S479A/S510A and rMV-S510A 
(Fig. 4C and D). Infection with the rMV-S479A mutant also tended to induce higher 
cytokine levels compared with wt-MV infections. Therefore, it can be seen that 
up-regulation of viral gene expression during the early phase of rMV infection was 
accompanied by high levels of cytokine induction. 
To further evaluate the influence of N-phosphorylation on virus growth, the 
author investigated the relative phosphorylation levels of the N protein at each time 
point. From 16 hpi to 6 dpi, the relative phosphorylation level of the N protein was 
constant in the 293SLAM cells (Fig. 4E). During the multi-step growth analysis, viral 
titers at the plateau phase inversely correlated with the phosphorylation level of the N 
protein. Titers for the cell-free virus showed a high inverse correlation with 
N-phosphorylation intensity, with a coefficient of determination (R2) of 0.82 
(P < 0.001) at 3–6 dpi (Fig. 4F). The R2 for the cell-associated virus was 0.69 
(P < 0.001), and was also significantly inverse correlated (Fig. 4G). These regression 
curves showed exponential trend lines. The intensity of N-phosphorylation seems to 
have a strong influence on the plateau-phase titer during multi-step growth. Intensely 
phosphorylated N protein caused a reduction in viral titer during the latter phase of 
infection. Conversely, N-phosphorylation intensity and early-phase viral titers did not 
show a significant correlation, suggesting that the difference in virus growth during the 
early phase of infection is not caused by different phosphorylation intensities of the 
N-protein. Taken together, N-phosphorylation status affects virus gene expression, and 
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N-phosphorylation intensity affects the titers selectively during the plateau phase of 
multi-step growth kinetics. 
 
2.3. Nucleocytoplasmic trafficking and N-M protein interaction are independent of 
N-phosphorylation. 
 
The phosphorylation sites of the N protein are within the C-terminal tail region, and 
therefore the author focused on the influence of N protein C-terminal functions, such as 
nucleocytoplasmic transport (Sato, et al., 2006) and binding to the P (Bernard, et al., 
2009) and M proteins (Iwasaki, et al., 2009). Our previous research identified a nuclear 
export signal and a nuclear localizing signal for the MV N protein. These signal 
sequences were prerequisites for nucleocytoplasmic transport (Sato, et al., 2006). The N 
protein is imported into the nucleus; however, its trafficking mechanism and 
significance have not been fully clarified. Transiently expressed wt-N, and its 
phosphorylation mutants in HEK 293 cells were mainly localized in nuclear foci, with 
no significant difference in localization observed (Fig. 5A). This suggests that nuclear 
trafficking of the N protein is not under the regulation of N-phosphorylation. 
It is apparent that N-P protein interaction is not affected by the 
phosphorylation status of the N protein (Fig. 1B). The M protein also associates with 
the N protein tail region, and assists in virus assembly (Iwasaki, et al., 2009). N protein 
mutants and the M protein were transiently co-expressed in HEK 293 cells, and 
coimmunoprecipitation assay was conducted. As a result, no significant changes in N-M 
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association were observed among N protein mutants (Fig. 5B). Moreover, under the 
presence of the P protein, there was also no difference in co-immunoprecipitation of the 
wt-N, N mutants, P, and M proteins (Fig. 5C). To investigate the influence of other viral 
proteins on N, P, and M protein binding, the author conducted immunoprecipitation 
experiment using wt-MV- or rMV-infected cells. As with the transcription experiment, 
no differences were observed in N, P, and M protein interaction (data not shown). 
Taken together, these results indicate that nuclear trafficking of the N protein, N-P 
interactions, and N-M interactions are not regulated by N-phosphorylation. Alterations 
in growth of the rMVs were not caused by changes in these factors. 
 
2.4. Influence of N-phosphorylation on viral RNA stability. 
 
The viral genome tightly associates with the N protein to form the nucleocapsid and is 
protected from RNases and siRNAs (Bhella, et al., 2004; Bitko and Barik, 2001; Moyer, 
et al., 1991). The author evaluated turnover of the viral genomic and antigenomic RNAs 
by pulse-chase experiments to determine any differences in the encapsidation ability of 
the N protein. Encapsidated RNAs of rMV-S479A were rapidly degraded, while those 
of rMV-S479A/S510A were relatively stable compared with wt-MV or rMV-S510A 
(Fig. 6A). This suggested that the stability of an encapsidated RNA was affected by the 
phosphorylation status of the N protein. The author further analyzed the relationship 
between the phosphorylation of the N protein and binding to the viral genome using a 
nuclease protection assay. In agreement with the results of the pulse-labeling 
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experiments, the genomic RNA protection rate of S479A/S510A was highest, reaching 
52.8%. In contrast, genomic RNAs coated with wt-N and S510A provided 30.2 and 
33.4% protection, respectively. The protection rate of S479A was limited to 10.3% (Fig. 
6B). The viral genome protection rate significantly correlated with viral titers during the 
plateau phase of multi-step growth kinetics (cell-associated virus: R2 = 0.66, P < 0.001; 
cell-free virus: R2 = 0.91, P < 0.001) (Fig. 6C). The protection rate inversely correlated 
with the phosphorylation level of the N protein (R2 = 0.96, P < 0.001) (Fig. 6D). These 
correlations also showed an exponential relationship as in Fig. 4F and 4G, implying that 
the influence of N-phosphorylation on the plateau phase of multi-step growth kinetics is 
a result of differences in the stability of the viral genomic RNA. Collectively, the 
phosphorylation intensity of the N protein affects the stability of the viral genomic RNA, 
and the viral titer during late-phase infection strongly depends upon viral genome 
stability. 
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DISCUSSION 
 
In CHAPTER 2, the author have demonstrated that phosphorylation of the N protein 
affects viral gene expression and viral genomic RNA stability. It has been reported that 
the P protein has two distinct binding sites for the free N protein and the N-RNA 
complex (Karlin, et al., 2003), and therefore the P protein is thought to be a carrier that 
binds free N proteins for delivery to the nascent replicating viral N-RNA complex for 
efficient encapsidation (Curran, et al., 1996; Leyrat, et al., 2011). It has also been 
reported that the P protein reduces non-specific binding of the N protein to cellular 
RNA (Curran, et al., 1996). Thus, the P protein seems to play important roles in 
supporting viral genome encapsidation; changes in the phosphorylation status of the N 
protein via N-P interactions may also be required for appropriate formation of the 
nucleocapsid. In rabies virus, it has been reported that the phosphorylation level of the 
N protein associated with the P protein is kept low to strengthen its affinity for viral 
RNA (Huber, et al., 1991; Wu, et al., 2002; Kawai, et al., 1999). Consistent with these 
findings, the author demonstrated significantly less phosphorylation of the wt-N protein 
associated with the P protein, compared with the highly phosphorylated wt-N protein 
expressed alone (Fig. 2). Hence, the P protein functions as a carrier of the N protein and 
seems to maintain the N protein at a lower phosphorylation state for effective 
encapsidation of the viral genome. 
 In the one-step growth experiments using rMVs, the phosphorylation of the N 
protein affected viral growth kinetics. The wt-MV showed delayed growth kinetics 
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compared with the rMVs (Fig. 3A and B). The viral titer and N protein level for the 
wt-MV were similarly attenuated during the early growth phase until 24 hpi (Fig. 3A, B, 
4A and B). This delay in wt-MV growth can be attributed to down-regulation of viral 
gene expression. These results are not consistent with those that have reported in 
CHAPTER1. The author demonstrated that mutations of the N-phosphorylation sites 
(S479A, S510A, and S479A/S510A) caused down-regulation of viral transcription in a 
minigenome assay (Hagiwara, et al., 2008; Sugai, et al., 2012). As with these data, 
some past reports that investigated the function of viral protein phosphorylations have 
suggested these kinds of discrepancies between viral transcriptional activity and growth; 
mutations at constitutive phosphorylation sites of the human respiratory syncytial virus 
(RSV) P protein (232A/237A and 116L/117R/119L/232A/237A) did not have 
significant impact on viral transcription and replication in a minigenome assay, while 
recombinant viruses with mutated phosphorylation sites (rA2-PP2 and rA2-PP5) 
showed significantly reduced growth kinetics compared with wild-type virus (Lu, et al., 
2002). High-turnover phosphorylation at S54 was not required for viral RNA synthesis 
and formation of N-P and P-L protein complexes in transfection experiments (Asenjo, et 
al., 2005), whereas an absence of S54 phosphorylation caused attenuation of viral titers 
because the S54 phosphorylation is involved in the viral uncoating step (Asenjo, et al., 
2008). Thus, in functional analysis of viral protein phosphorylation, since it affects 
various steps of viral lifecycle, viral infection experiment sometimes shows different 
results from transfection experiment.  
 Past reports have demonstrated that strategic regulation of RNA synthesis is 
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required for effective evasion of the host defense system (Gainey, et al., 2008; Sun, et 
al., 2009; Fuentes, et al., 2010; Dillon and Parks, 2007). Likewise, the author 
hypothesized that wt-MV strategically down-regulated viral gene expression to evade 
the host defense system during the early phases of infection. It has been reported that 
transcription of the MV N gene causes cytokine induction in a dose- and 
time-dependent manner (Noe, et al., 1999). Additionally, inhibition of viral 
transcription by limited UV irradiation or ribavirin treatment reduced MV-induced 
cytokine expression, such as RANTES (CCL5) (Noe, et al., 1999; Schall, et al., 1988), 
which is thought to play an important role in response to virus infection by recruiting 
monocytes, macrophages, and virus-specific memory T cells (Dillon and Parks, 2007; 
Nakamichi, et al., 2005; Pazdrak, et al., 2002; Kujime, et al., 2000; Schall, et al., 1990). 
It was also reported that uncontrolled rapid viral RNA synthesis induces cell death and 
expression of cytokines such as interferon- and interleukin-6 (Sun, et al., 2009). Thus, 
a negative regulatory system of viral RNA production has been reported in some viruses 
(Sun, et al., 2009; Schmid, et al., 2010). The author demonstrated that attenuation of 
wt-MV viral gene expression activity during early growth phases contributed to reduced 
host immune responses (Fig. 4C and D). This feature of wt-MV could be advantageous 
in the context of real virus infections. 
 On the other hand, the differences in the plateau phase of multi-step growth 
kinetics were inversely correlated with phosphorylation intensity of the N protein (Fig. 
3C, D, and 4E). Reduction in the phosphorylation level of the N protein enhanced 
stability of encapsidated viral genomic RNA (Fig. 6A and B). These data indicate that 
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virus growth in the plateau phase is affected by stability of the encapsidated viral 
genomic RNA, which is in contrast to the early phases of infection. It has been 
previously reported that dephosphorylation of the N protein increases viral RNA 
encapsidation of the N protein in rabies virus (Yang, et al., 1999). Moreover, removal of 
the C-terminal tail of the N protein, which contains major phosphorylation sites, makes 
the nucleocapsid more rigid in MV (Schoehn, et al., 2004). These data suggest that the 
negatively charged N protein and the viral genomic RNA repel each other and that this 
electrostatic repulsion weakens encapsidation of the viral genome. Therefore, excessive 
phosphorylation of the N protein interferes with the rapid assembly and/or strong 
association of the N-RNA complex. During one-step growth kinetics, total 
phosphorylation intensity of the N protein and viral genome stability do not have a 
strong impact on virus production (Fig. 3A and B). During an MV infection, the 
genomic RNA mainly replicates at around 12–24 hpi, and accumulates exponentially 
during this phase (Plumet, et al., 2005). Because an adequate amount of genomic RNA 
was supplied during this phase, viral RNA stability does not have a strong influence 
during the early phases of infection. In contrast, viral genome replication is restricted to 
the latter phases of infection. Hence, viral genome stability has a strong selective effect 
on the late phase of multi-step growth kinetics. 
In the present study, the author demonstrated that N-phosphorylation affected 
viral growth by altering viral gene expression and genomic RNA stability, whereas 
nucleocytoplasmic transport of the N protein (Fig. 5A), N-P interactions (Figs. 1B and 
5C), and N-M interactions (Fig. 5B and C) remained unaltered. During the early phases 
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of infection, proper phosphorylation of the N protein controls viral gene expression, and 
this regulation was required for efficient evasion of the host immune response. 
Phosphorylation intensity of the N protein at plateau growth phases regulates viral 
genome stability, and these data provide new insights into the machinery regulating 
post-replication viral RNAs. The N protein may regulate its own phosphorylation (S479 
and S510), thereby optimizing its function at each step of the viral life cycle for 
efficient viral propagation. Further analysis of the phosphorylation and 
dephosphorylation mechanisms of the N protein would help our understanding of the 
biological significance of N protein phosphorylation regulation. 
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FIGURE LEGENDS 
 
Fig. 1 
Phosphorylation status of wt-N protein and phosphorylation mutants (S479A, S510A, 
and S479A/S510A) under various conditions. (A) HEK 293 cells were transfected with 
pCAGGS expression vectors encoding wt or mutant N proteins. N proteins expressed 
alone in HEK 293 cells were labeled with 32P or 35S and precipitated with an anti-N 
polyclonal antibody. (B) N proteins were transiently expressed with the P protein in 
HEK 293 cells, labeled with 32P or 35S, and co-immunoprecipitated with the P protein 
using an anti-P polyclonal antibody and quantified. (C) 293SLAM cells were infected 
with wt or rMVs (rMV-S479A, rMV-S510A, and rMV-S479A/S510A) at an MOI of 
0.001, and labeled with 32P or 35S. The bar graphs below each image represent relative 
phosphorylation levels (32P-N/35S-N) for each N protein. 
 
Fig. 2 
Phosphorylation of free N protein (N0) and P-associated N protein. (A) HEK 293 cells 
transiently expressing wt-N protein, with or without the P protein, were labeled with 32P 
or 35S, and immunoprecipitated with anti-N or anti-P antibodies as appropriate. The bar 
graph shows the relative phosphorylation levels (32P-N/35S-N) of the N protein. Error 
bars indicate standard deviations. **P < 0.01. Location of the wt-N protein was shown 
by immunofluorescence using the anti-N monoclonal antibody 8G (Masuda, et al., 
2006), with nuclei stained with Hoechst 33342. (B) The same experiment was 
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conducted using an N protein mutant (mN, 74-77A). 
 
Fig. 3 
One- and multi-step growth kinetics of rMVs. 293SLAM cells were infected with 
wt-MV or rMVs (rMV-S479A, rMV-S510A, and rMV-S479A/S510A) at an MOI of 1.0. 
Cells were harvested at 8, 12, 16, 20, and 24 hpi, and titrations (TCID50/ml) of the 
cell-free virus (A) and cell-associated virus (B) conducted. 293SLAM cells infected 
with the rMVs at an MOI of 0.001 were harvested at 12, 24, 48, 72, 96, 120, and 
144 hpi, and the titers of cell-free virus (C) and cell-associated virus (D) measured. 
 
Fig. 4 
Viral N protein accumulation of wt-MV and rMVs, and their phosphorylation status. 
(A) 293SLAM cells were infected with wt-MV and rMVs (rMV-S479A, rMV-S510A, 
and rMV-S479A/S510A) and lysed at 8, 16, 20, and 24 hpi (MOI = 1.0), or at 2, 3, 4, 5, 
and 6 dpi (MOI = 0.001). Lysates were subjected to 10% SDS-PAGE and 
immunoblotting with an anti-N polyclonal antibody. (B) Relative expression levels 
(nucleoprotein/GAPDH) of wt-N and phosphorylation mutants of the N protein. (C) 
IFN- induction and (D) RANTES induction by wt-MV and rMVs. *P < 0.05, 
**P < 0.01. (E) Relative phosphorylation levels of wt-N and N mutants in 293SLAM 
cells at each time point. (F and G) Correlation between phosphorylation level of the N 
protein and plateau-phase viral titers (3–6 dpi) during multi-step growth kinetics 
(cell-free and cell-associated virus). R2, coefficient of determination; P, P-value. 
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Fig. 5 
Nucleocytoplasmic trafficking and N-M protein interaction are not regulated by 
N-phosphorylation. (A) HEK 293 cells were transfected with vectors encoding wt or N 
protein mutants. Locations of N proteins were visualized using an anti-N antibody. 
Nuclei were stained with Hoechst 33342. (B) Transiently expressed N protein and its 
phosphorylation mutants (S479A, S510A, and S479A/S510A) complexed with the M 
protein in HEK 293 cells were co-immunoprecipitated with an anti-M polyclonal 
antibody. Precipitated N and M proteins were detected with anti-N and anti-M 
polyclonal antibodies, respectively. (C) HEK 293 cells were transfected with plasmids 
encoding the N, P, and M proteins. Expressed proteins were precipitated with anti-N 
monoclonal antibody and detected by immunoblotting using anti-N, -P, and -M 
polyclonal antibodies. 
 
Fig. 6 
Phosphorylation intensity of the N protein inversely correlated with viral genome 
stability. (A) 293SLAM cells were infected with wt-MV or rMVs (S479A, S510A, and 
S479A/S510A) at an MOI of 0.01. Infected cells were pulse chased with tritium. Cells 
and supernatants were collected at 0, 6, 24, and 48 h after labeling, and radioactivity 
measured. (B) 293SLAM cells were infected with wt-MV or rMVs, and each N-RNA 
complex in the cell lysate was treated with MNase. Viral genomic RNA of MNase 
treated, or untreated samples were quantified by RT-PCR. Error bars indicate standard 
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deviations. **P < 0.01; n.s., not significant. (C) Correlation between viral genome 
protection rate and viral growth of wt or mutant MVs. (D) Viral genome protection rate 
and the phosphorylation level of N proteins. 
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CHAPTER 3 
 
 
Novelly Identified Phosphorylation Site of Nucleoprotein: 
 
Nucleocapsid assembly of measles virus requires a phosphorylation 
modification on the core domain of nucleoprotein 
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INTRODUCTION 
 
The most defined role of MV N protein is encapsidation of viral genomic and 
antigenomic RNA (Bitko and Barik, 2001; Moyer, et al., 1990), where N proteins 
tightly associate with the viral genome to form an N-RNA complex that is template for 
viral transcription and replication (Rima and Duprex, 2009). In the CHAPTER 1 and 2, 
the author have demonstrated that the major phosphorylation sites of N protein (S479 
and S510) are involved in various stages of the viral life cycle such as viral gene 
expression, virus growth rate, and viral genome RNA stability (Sugai, et al., 2013; 
Sugai, et al., 2012; Hagiwara, et al., 2008). However, despite double mutation of the 
major phosphorylation sites of MV N protein, it was still phosphorylated, albeit to a 
lesser extent (Sugai, et al., 2012). This suggested that the N protein had unidentified 
phosphorylation site. Moreover, it has been reported that N protein undergoes 
phosphorylation at both serine and threonine residues, and the phosphorylation intensity 
of the phosphothreonine was weaker than for the phosphoserine (Gombert, et al., 1995; 
Robbins, et al., 1980; Robbins and Bussell, 1979); this also indicated that there was 
unidentified novel phosphothreonine residue within the N protein. This minor 
phosphorylation residue has yet to be identified, and their functions are poorly 
understood. 
In this chapter, the author predicted nine putative phosphorylation sites within 
the N protein by mass spectrometry (MS) analyses, and identified new phosphorylation 
site of N protein using alanine substitution mutants for each putative phosphorylation 
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site. Furthermore, the role of the new phosphorylation site in viral reproduction was 
examined. Here, the author demonstrated that phosphorylation at T279 is functionally 
indispensable for nucleocapsid formation. 
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MATERIALS AND METHODS 
 
Cells, plasmids and antibodies 
Cos7, 293, 293T, and Vero cells were propagated in Dulbecco’s modified Eagle’s 
medium (DMEM) (Sigma) supplemented with 5% fetal bovine serum (JRH Bioscience), 
2 mM L-glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in 5% 
CO2. COBL cells were maintained in a RPMI-1640 medium (Sigma) with the same 
supplements as described above. pCAGGS mammalian expression vectors (Niwa, et al., 
1991) encoding wild-type N (wt-N), N mutants, and P genes from the HL strain of MV 
(Kobune, et al., 1996) were prepared as described previously (Sugai, et al., 2012). 
Generation of a polyclonal anti-MV N antibody has also been described previously 
(Hagiwara, et al., 2008). 
 
Matrix-assisted laser desorption/ionization/time-of-flight (MALDI-TOF/ TOF) MS 
analysis 
MV-infected COBL cells were lysed, and NC-associated N proteins were purified by 
cesium chloride (CsCl) gradient centrifugation as described below. The N protein was 
separated by SDS-PAGE and stained with Coomassie brilliant blue. The band 
corresponding to the N protein was excised from the gel and destained five-times with 
50 mM NH4HCO3 in 50% methanol. The N protein was then subjected to in-gel 
digestion with trypsin or V8 protease at 37°C for 16 h as previously described 
(Hagiwara, et al., 2008; Huang, et al., 2011). The digested peptides of N protein were 
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separated by nanoflow liquid chromatography (LC) (KYA Technologies Corporation) 
and analyzed by MALDI-TOF/TOF MS (4700 proteomics analyzer) as described 
previously (Hagiwara, et al., 2008). Detected peptides were identified by a database 
search using MASCOT ver. 2.0 (Matrix Science). 
 
Immunoprecipitation Assay 
Cos7, 293T, and Vero cells were transfected with plasmids containing wt-N and N 
mutants. At 24 h post-transfection, 0.38 mCi/ml of 32P (phosphorus-32 radionuclide, 
PerkinElmer) or 0.06 mCi/ml of 35S (EasyTag Express Protein Labeling Mix, 
PerkinElmer) was added to the media, and incubated at 37°C for 24 h. Cells were 
harvested and lysed in lysis buffer, 0.5 mM EDTA and 0.5% Triton X-100 in phosphate 
buffered saline (PBS) supplemented with Protease Inhibitor Cocktail (BD Biosciences) 
and PhosSTOP Phosphatase Inhibitor Cocktail (Roche) for 1 h at 4°C, and cell debris 
was removed from the lysate by centrifugation. The lysate was incubated with protein A 
sepharose CL-4B beads (Amersham Biosciences) and anti-MV N polyclonal antibody 
for 16 h at 4°C. The beads were collected, washed 5 times with PBS and suspended in 
2× Laemmli’s sample buffer. Component proteins were separated by SDS-PAGE, and 
detected by radioactivity using an Imaging Plate and phosphorimager FLA-5100 
(Fujifilm). 
 
Minigenome expression assay 
Precise methods for the minigenome experiment were described previously (Sugai, et 
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al., 2012). Briefly, 293 cells in 24-well plates were transfected with N, P, and L protein 
expression plasmids using Lipofectamine LTX Reagent (Invitrogen) and Plus Reagent 
(Invitrogen). After 24 h, viral minigenomic RNA encoding the firefly luciferase gene 
were transfected with Lipofectamine 2000 Reagent (Invitrogen). The following day, 
cells were lysed in Passive Lysis Buffer (Promega), and luciferase activity was 
measured using a PicaGene Luminescent Kit (Tokyo Ink Manufacturing) according to 
the manufacturer’s instructions. Fluorescence intensity was detected by Mini Lumat LB 
9506 (Berthold). 
 
N-P protein binding assay 
Cos7 cells were transfected with either wt-N or mutant N protein (T279A) expression 
plasmids, and a P protein expression plasmid using Lipofectamine LTX Reagent and 
Plus Reagent. The following day, cells were labeled with 35S (0.06 mCi/ml) at 37°C for 
24 h. The cells were lysed, and the lysate was incubated with Protein-A Sepharose 
CL-4B and anti-N protein antibody. The precipitated proteins were separated by 
SDS-PAGE and detected with phosphorimager FLA5100. 
 
Indirect immunofluorescence assay 
Cos7 cells were transfected with expression vectors for wt-N, N protein mutants 
(T279A, T279D, T279E, S479A/S510A, ST8A, and ST11A), and P protein using 
FuGENE 6 Transfection Reagent according to the manufacturer’s instructions. At 24 h 
post-transfection, cells were fixed and permeabilized with 3% paraformaldehyde/PBS 
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and 0.5% Triton X-100/PBS, respectively. The cells were incubated with polyclonal 
anti-N protein antibody and monoclonal anti-P protein antibody followed by incubation 
with 1:2000 dilution of Alexa Fluor 488 F(ab’)2 fragment of goat anti-rabbit IgG (H+L) 
(Invitrogen) and Alexa Fluor 568 F(ab’)2 fragment of goat anti-mouse IgG (H+L) 
(Invitrogen) supplemented with Hoechst 33342 (Cambrex Bio Science). Fluorescence 
was visualized by confocal laser scanning microscope Fluoview FV1000-D system 
(Olympus). 
 
Nucleocapsid purification 
Cos7 cells were transfected with the expression plasmid for N protein or its mutants 
using FuGENE 6 Transfection Reagent (Roche Applied Science) according to the 
manufacturer’s instructions. At 48 h post transfection, cells were lysed in TNE buffer 
(10 mM Tris (pH 7.8), 150 mM NaCl, and 1 mM EDTA) supplemented with 1% NP40 
and Protease Inhibitor Cocktail at 4°C for 30 min. The lysate was layered onto 1.5 ml 
each of 25%, 30%, and 40% CsCl (w/v) gradients in TNE buffer and centrifuged in a 
Beckman Sw55Ti rotor for 2 h at 55,000 rpm. The fraction containing the nucleocapsid 
was diluted with TNE and centrifuged at 55,000 rpm to precipitate the nucleocapsid, 
which was resolved in an appropriate volume of PBS. 
 
Western blot analysis 
Expression plasmids for wt-N and T279A were transfected in Cos7 cells, and each cell 
lysate was subjected to western blot analysis to detect expression levels of the N protein 
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relative to an internal control, GAPDH. The cell lysates were then separated by CsCl 
gradient centrifugation. The NC fraction was collected and further centrifuged to 
precipitate the NC-like particles. The yields of the NC-like particles were also 
visualized and quantified by western blotting. Briefly, the lysate of N protein 
transfected cells and purified nucleocapsids were subjected to 10% SDS-PAGE, and the 
separated proteins were transferred onto Immobilon-P Transfer Membrane (Millipore). 
The membrane was blocked with BlockACE (DS Pharma Biomedical), and then 
incubated with anti-N polyclonal antibody for 1 h at 37°C. The membrane was washed 
five times with 0.05% Tween/PBS and incubated with 1:2000 dilution of polyclonal 
goat anti-rabbit horseradish peroxidase-conjugated immunoglobulins (Dako 
Cytomation) for 1 h at 37°C. Immunoreactive bands were detected using ECL Western 
blotting detection reagents (GE Healthcare). Scanning of chemiluminescence was 
performed with a luminescent image analyzer LAS-1000UV mini system (Fujifilm). 
 
Electron microscopy 
Cos7 cells were transfected with wt-N or N-T279A expression plasmids using Plus 
Reagent and Lipofectamine LTX Reagent, and self-assembled NC-like particles were 
purified 2 days post-transfection. Sample preparation for the electron microscopy was 
performed as previously described (Hagiwara, et al., 2008). Briefly, purified NC-like 
particles were spotted on a copper grid coated with collodion, and incubated for 5 min 
at room temperature. The samples were then negative-stained with 2% uranyl acetate, 
and observed under an electron microscope H7000 (Hitachi). 
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Limited Proteolysis 
Purified NC fraction of wt-N, N-T279A, and heat-denatured wt-N (for 10 min at 95°C) 
were equally divided into eight tubes, and each aliquot was subjected to 0, 0.1, 0.25, 0.5, 
1.0, 2.5, 5.0, or 10.0 g/ml of trypsin treatment for 1 h at 37°C. The reactions were 
stopped by adding SDS sample buffer and heating for 5 min at 95°C, and then subjected 
to SDS-PAGE. The proteolytic bands were detected by immunoblot using anti-N 
polyclonal antibodies. 
 
Bacterial alkaline phosphatase (BAP) treatment and NC fractionation 
Cos7 cells in 6-cm dishes were transfected with expression plasmids for wt-N, 
N-T279A, and ST10A using FuGENE 6 Transfection Reagent. At 24 h 
post-transfection, the nucleocapsids were purified by CsCl gradient centrifugation and 
dissolved in 200 mM Tris-HCL buffer (pH 8.0) supplemented with Protease Inhibitor 
Complete EDTA-free (Roche Diagnostics). Each sample was incubated with or without 
1.5 units of BAP and PhosSTOP Phosphatase Inhibitor Cocktail for 2 h at 65°C, and 
then 500 mM NaCl was added and incubated for 1 h at 37°C. NC-like particles were 
separated by CsCl gradient centrifugation (0.6 ml of 30% glycerol (v/v), 1.2 ml of 20%, 
1.4 ml of 30%, and 1.4 ml of 40% CsCl (w/v) in TNE buffer) in a Beckman Sw55Ti 
rotor for 16 h at 36,000 rpm, and the gradients were divided into seven fractions. N 
proteins contained in each fraction were immunoprecipitated with Protein A Sepharose 
CL-4B and anti-N polyclonal antibodies, and were subjected to SDS-PAGE and western 
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blot analysis to quantify N protein levels. 
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RESULTS 
 
3.1. Identification of a novel phosphorylation site within MV-N protein. 
 
In our previous paper, MALDI-TOF/TOF MS and ESI-Q-TOF MS analysis of MV-N 
protein was conducted, and two major phosphorylation sites were identified from the 
tryptic peptides of N protein purified from N-plasmid transfected cells (Hagiwara, et al., 
2008). However, minor phosphorylation sites of N protein were not identified from 
these tryptic peptides. Therefore, in this study, the author re-examined minor 
phosphorylation of the N protein by MALDI-TOF/TOF MS analysis using trypsin 
digested N protein derived from MV-infected cells. Additionally, investigation of the 
minor phosphorylation was performed using V8 protease-digested N protein. In the 
latter case, phosphorylated peptides were selectively detected and analyzed by 
MALDI-TOF/TOF MS. As a result, the peptides digested with trypsin or V8 protease 
covered 70.5% of the N protein sequence (Fig. 1A and 1B), and nine putative 
phosphorylation sites were predicted: T279, S294, S295, S407, S418, T454, S456, S457, 
and S460. The author further investigated these putative phosphorylation sites to 
identify responsible sites for the minor phosphorylation of N protein. The author 
prepared alanine substitution mutants for each putative phosphorylation site of N 
protein, and examined phosphorylation levels of each putative phosphorylation site by 
32P labeling and immunoprecipitation. Mutants used in this study are shown in Fig. 2A. 
As a result, the T279 site was remarkably phosphorylated among these nine putative 
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phosphorylation sites, with a phosphorylation rate of 14.3% for wt-N protein in Cos7 
cells (Fig. 2B). The phosphorylation rate of T279 in Vero and 293T cells was also 
investigated, but did not observe a significant change in these cells compared with Cos7 
cells (Fig. 2C). This indicated that the minor phosphorylation at T279 was not cell-type 
specific phenomenon. Phosphorylation at the eight remaining putative phosphorylation 
sites occurred at trace level, and therefore these sites may not be phosphate group 
acceptors. Additionally, phosphorylation signals were barely detected in ST11A, where 
two major and nine minor putative phosphorylation sites were alanine-substituted. 
The Paramyxovirus N protein possesses a highly conserved domain at amino 
acids (aa) 258-357 which is referred to as the central conserved region (CCR) (Fig. 3A), 
and is known to be important for N protein function (Liston, et al., 1997; Karlin, et al., 
2002). In previous (Hagiwara, et al., 2008) and present MS analysis (Fig. 1), aa 250-278 
and 298-324 were not covered within the N protein CCR. This region includes six 
serine and threonine residues: T259, S268, T272, S298, T309, and S319. The author 
generated additional alanine mutants, named ST14A and ST17A (Fig. 3B), and 
examined whether the slight phosphorylation levels in ST11A were responsible for 
these sites. Phosphorylation of ST14A and ST17A was similar to that for ST11A (Fig. 
3C), suggesting that these six sites within CCR were not phosphate group acceptors. 
Trace level phosphorylation which was detected in ST11A, ST14A, and ST17A 
appeared to be non-specific phosphorylation that occurs at very low rates. 
 
3.2. T279 is an essential phosphorylation site for N protein function. 
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To identify the phosphorylation sites required for N protein function from the nine 
putative sites, the author prepared alanine-substituted mutants of N protein and 
measured each N protein activity by minigenome reporter assay. In agreement with the 
previous data, a double mutant of the major phosphorylation sites S479A/S510A 
showed 46.3% activity compared with that for the wt-N protein (Fig. 4A), whereas an 
alanine substitution mutant of the T279 site showed a complete loss of activity and did 
not aid transcription and replication, indicating the T279 site is functionally important. 
Alanine substitution mutant at the eight putative phosphorylation sites other than T279 
(ST8A) showed no reduction in activity compared with wt-N protein. Additionally, the 
activity of an ST10A mutant (where two major phosphorylation sites and eight putative 
phosphorylation sites other than T279 were substituted with alanine) reduced activity to 
36.6%. There was no statistically significant difference between S479A/S510A and 
ST10A activity. Thus, the eight putative phosphorylation sites other than T279 were not 
required for N protein function, but the T279A mutant was functionally indispensable. 
Therefore, the author investigated the T279 site further using N protein mutants whose 
T279 sites were substituted with aspartic acid (D) and glutamic acid (E). The T279D 
and T279E mutants showed no activity similar to the T279A mutant in the minigenome 
assay (Fig. 4B). Since substitutions of T279 to acidic residues did not mimic the 
phosphorylation of T279, constitutively charged T279 may be undesirable for N protein 
function. 
 The N protein possesses a nuclear localization signal and nuclear export 
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signal for nucleocytoplasmic transport, and the N protein expressed alone in cultured 
cells localizes to the nucleus (Sato, et al., 2006; Huber, et al., 1991). To investigate the 
significance of the T279 site, the localization of the putative phosphorylation site 
mutants including a series of T279 mutants were examined by indirect fluorescent 
antibody (IFA) assay. The N protein mutants S479A/S510A, ST8A, and ST10A showed 
nuclear localization identical to wt-N protein, while T279 mutants showed diffuse 
cytoplasmic distribution (Fig. 5A and B). Thus, T279 mutants showed abnormal 
properties by IFA assay. The P protein has been known to retain N protein in the 
cytoplasm and co-localizes with the N protein (Huber, et al., 1991). Under the presence 
of the P protein, the T279A mutant exhibited a dotted co-localization pattern with the P 
protein in the cytoplasm, similar to that seen for the wt-N protein (Fig. 5C).  
P protein is a major binding protein of the N protein and is required for viral 
transcription and replication (Bernard, et al., 2009; Bourhis, et al., 2005). The P protein 
functions as a carrier of the N protein to nascent replicating viral N-RNA complexes for 
efficient encapsidation (Curran, 1996), stabilizes NC by regulating the phosphorylation 
status of N protein (Sugai, et al., 2013), and prevents nonspecific binding of the N 
protein to host cellular RNA (Curran, 1996). To probe the mechanism of deactivation 
for the T279A mutant in a minigenome assay, the binding abilities of wt-N and T279A 
to P protein were investigated by co-immunoprecipitation assay. Transiently expressed 
wt-N or T279A with P protein were labeled with 35S, and immunoprecipitated using 
anti-N polyclonal antibodies. There were no differences in co-precipitation of the P 
protein (Fig. 5D); this finding and dotted co-localization with P protein (Fig. 5C) 
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suggests that T279A mutant possesses normal binding ability with P protein, and 
therefore loss of activity of the T279A mutant in the minigenome assay was 
independent of N-P interactions. 
 
3.3. T279 phosphorylation site of N protein is a prerequisite for NC formation. 
 
The region around T279 of MV-N protein is called CCR and has been reported to 
function as an N-N and N-RNA interaction domain to form NCs (Karlin, et al., 2002; 
Myers, et al., 1999; Terao-Muto, et al., 2008). Multiple sequence alignment of CCR 
among Paramyxoviridae revealed that T279 is highly conserved (Fig. 3A). Therefore, 
the author examined whether the T279 phosphorylation site was required for NC 
formation. NC formation ability was tested by measuring and comparing the amount of 
NC-like particles in N plasmid transfected cells between the wt-N and T279A mutant. 
The expression of wt-N protein and T279A in Cos7 cells were similar, while purified 
NC-like particles from T279A transfected cell lysates were significantly reduced 
compared with wt-N protein (Fig. 6A). Thus, alanine substitution at T279 caused a 
remarkable impairment of NC formation, and the T279 mutants showed a loss of 
activity in the minigenome assay. 
Of note, the T279A mutants were detected in the NC fraction in CsCl gradient 
centrifugation experiment (Fig. 6A), although the T279A mutant lost activity in the 
minigenome assay (Fig. 4A). To clarify that the N proteins acquired from the NC 
fraction formed correct NC structures, the author subjected them to electron microscopy. 
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The wt-N protein showed a typical herringbone structure, while the T279A mutant from 
the NC fraction did not form a correct NC structure, and various sized aggregates were 
detected (Fig. 6B), suggesting that the T279A mutant did not retain the ability of 
self-assembly and/or RNA encapsidation. 
 Furthermore, the author generated a full-genomic plasmid containing the 
T279A mutation in the N protein and attempted to rescue the T279A recombinant virus 
using a reverse genetics system that we had previously established (Sugai, et al., 2013; 
Terao-Muto, et al., 2008; Myers, et al., 1997). However, we were unable to rescue the 
T279A mutant virus. This seems to be attributed to a loss of N protein functions; the 
T279A mutant nucleoprotein could not correctly encapsidate the RNA (Fig. 6B) and did 
not support viral transcription and replication (Fig. 4A and B). 
 
3.4. Phosphorylation modification at T279 is required for NC formation. 
 
N protein consists of a highly structured N-core domain (aa 1-400) and an intrinsically 
disordered N-tail domain (aa 401-525) (Sato, et al., 2006; Bourhis, et al., 2005). A 
correctly folded N-core domain is resistant to proteases including trypsin (Myers, et al., 
1997; Heggeness, et al., 1981). The tertiary structure of the T279A mutant was 
evaluated by limited proteolysis to determine whether the loss of self-assembly was due 
to the decay of N-core conformation or absence of phosphorylation. Plasmids for wt-N 
and T279A were transfected into Cos7 cells, and each N protein was purified from the 
NC fraction of CsCl gradient centrifugation. The purified N proteins were subjected to 
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limited proteolysis with various concentrations of trypsin. Indeed, the 43.5 kDa core 
domain of the wt-N protein was resistant to trypsin hydrolysis (Fig. 7A). 
Heat-denatured wt-N protein showed a different degradation pattern, and various 
proteolytic products less than 43.5 kDa were detected (Fig. 7B). The T279A mutant 
showed trypsin resistance, and its degradation pattern was identical to that of wt-N 
protein (Fig. 7C). These results imply that the tertiary structure of the core domain of 
the T279A mutant retained structural integrity. Thus, alanine substitution of T279 did 
not cause denaturation of the tertiary structure of N-core domain, but absence of the 
T279 phosphorylation seemed to be critical for NC formation. 
 To investigate the significance of T279 phosphorylation on NC formation, the 
author conducted dephosphorylation of T279 with BAP and examined whether this 
caused abnormalities in NC formation. Previous reports demonstrated that deficient 
NC-like particles could be discriminated by CsCl centrifugation in Sendai virus (Myers, 
et al., 1999; Myers, et al., 1997; Buchholz, et al., 1993). Using the same conditions, the 
author examined whether this method was applicable to MV-N protein. The wt-N and 
T279A transfected cell lysates were subjected to CsCl gradient centrifugation to 
discriminate between normal and deficient NC-like particles. The gradients were 
divided into seven fractions, and N protein in each fraction was detected by western blot. 
The NC-like particles of wt-N were mainly detected in fraction 6 to 7 (Fig. 8A), while 
aggregates of the T279A mutant were broadly detected from fraction 1 to 7 (Fig. 8B) 
indicating the deficient NC-like particles formed various size aggregates. Thus, normal 
NC-like particles could be discriminated from deficient aggregates. To demonstrate that 
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T279 phosphorylation is important in NC formation, the author then evaluated the 
influence of dephosphorylation of the ST10A mutant by examining whether the ST10A 
mutant could form normal NC-like particles in the presence or absence of BAP. All 
phosphorylation sites other than T279 are substituted with alanine residues in the 
ST10A mutant (Fig. 2A). Since there are no significant phosphorylation sites other than 
the 11 sites (Fig. 2B, 3B, and 3C), the influence of the BAP treatment on ST10A is 
equivalent to T279 dephosphorylation. NC-like particles from ST10A were mainly 
detected in NC fractions 6 to 7, similar to the intact NC-like particles, suggesting 
ST10A formed normal NC-like particles (Fig. 8C). ST10A with BAP treatment showed 
a wide distribution from fractions 2 to 7 (Fig. 8D), indicating that dephosphorylation of 
T279 caused a deficiency in NC formation. Furthermore, addition of a phosphatase 
inhibitor abrogated the NC deficiency caused by BAP treatment (Fig. 8E) indicating it 
was not caused by binding of BAP to N protein but by dephosphorylation at T279. 
Taken together, these results suggest that phosphorylation at T279 is a prerequisite for 
NC formation. 
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DISCUSSION 
 
From CHAPTER 1 to CHAPTER 2, the author have demonstrated that the major 
phosphorylation sites of N protein (S479 and S510) were involved in various stages of 
the viral lifecycle (Sugai, et al., 2012; Sugai, et al., 2013). Additionally, it has been 
shown that a double mutant of the major phosphorylation sites remained phosphorylated 
but to a lesser extent, suggesting unidentified phosphorylation sites within the N protein 
existed. In this chapter, nine putative minor phosphorylation sites of N protein were 
predicted by MS analysis. Moreover, the author demonstrated that a threonine residue at 
location 279 was notably phosphorylated among the putative minor phosphorylation 
sites and was a prerequisite for NC formation. 
 Since the late 1970s, it has been known that N protein undergoes 
phosphorylation at both serine and threonine residues, and that the phosphorylation 
intensity of phosphoserine was stronger than for phosphothreonine (Robbins, et al., 
1980; Robbins and Bussell, 1979). Additionally, in the 1990s, it was reported that the 
phosphorylation intensity of phosphoserine and phosphothreonine was 88% and 12%, 
respectively, of the total N-phosphorylation (Gombart, et al., 1995). In agreement with 
these reports, the author demonstrated that the phosphorylation intensity of a double 
mutant of the major phosphorylation sites (S479A/S510A) was 15.7% compared to 
wt-N protein, and the phosphorylation intensity of the T279 site was 14.3% of the total 
N-phosphorylation. This indicated that the intensity of major phosphorylation at serine 
residues was 84.3%, and almost all of the remaining 15.7% phosphorylation was due to 
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phosphorylation of T279. Furthermore, specific phosphorylation was not detected in the 
ST11A mutant (Fig. 2E and F), suggesting no significant phosphorylation sites other 
than the 11 sites already identified. In addition, alanine substitution at putative minor 
phosphorylation sites other than T279 did not have influence in a minigenome 
expression assay. Taken together, these data indicated that the functionally significant 
phosphorylation sites of N protein were limited to the two major phosphorylation sites 
(S479 and S510) and a minor T279 phosphorylation site. 
It was reported that free N protein and NC-associated N protein showed 
different antigenicity toward antibodies, and was explained as a conformational 
difference between the free N protein and NC-associated N protein (Kawai, et al., 1999; 
Gombert, et al., 1993; Hirano, et al., 1992). This suggested that conformational changes 
of N protein were required for NC formation. Furthermore, free N protein is 
phosphorylated only on serine residues, whereas the NC-associated N protein is 
phosphorylated on both serine and threonine residues (Gombart, et al., 1995), implying 
that threonine phosphorylation and subsequent conformational changes of N protein are 
a prerequisite to NC formation. In agreement with these studies, the author 
demonstrated that the T279A mutant did not form NC-like particles by electron 
microscopy. Additionally, the data also suggested that an absence of phosphorylation at 
the threonine residue resulted in a structural abnormality in the NC-like particle. Taken 
together, these data indicated that NC formation requires a conformational change of N 
protein that is switched by phosphorylation at T279. However, wt-N protein and T279A 
mutant harvested from NC fractions of CsCl density gradients did not show any 
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difference in proteolytic peptide patterns of trypsin digestion, indicating that the T279A 
mutant retained a normal tertiary structure similar to the wt-N protein. Thus, the 
conformational change required for NC formation was a quite small and cannot be 
discriminated from trypsin digestion patterns. Indeed, trypsin digestion of free N protein 
and NC-associated N protein resulted in similar degradation patterns (Gombart, et al., 
1995). Moreover, a double mutant of the MV-N CCR domain whose SL (residues 
228-229) were replaced by QD (NQD) did not cause any differences in trypsin digestion 
analysis, immunoprecipitation, and circular dichroism (CD) spectroscopy, while the 
mutant did not form normal NC-like particles by electron microscopy (Karlin, et al., 
2002). As the conformational change for NC formation could not be detected by CD 
spectroscopy, the change was not accompanied by a change in secondary structure. 
Thus, in the NC formation step, very small conformational changes are required for 
correct encapsidation. 
Since the CsCl gradient centrifugation assay suggested that the ST10A mutant 
formed normal NC-like particles, the major phosphorylation sites of N protein are 
dispensable for NC formation. This is consistent with a previous report demonstrating 
the N-tail region is not required for NC formation (Buchholz, et al., 1993). Here, we 
identified the T279 site as a new phosphate group acceptor site that is indispensable for 
NC formation. However, the phosphorylation intensity of T279 was low, and this minor 
phosphorylation was only 14.3% of the total N-phosphorylation. Moreover, substitution 
of T279 to acidic residues such as aspartic acid and glutamic acid also abrogated the 
phenotype of wt-N protein in a minigenome assay and in IFA. Thus, the 
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phosphorylation at T279 is not constitutive, and N protein is functionally inactive under 
circumstances where all N proteins are constantly phosphorylated at T279. Moreover, 
although the threonine residue of free N protein was not phosphorylated (Gombart, et 
al., 1995), 14.3% of the NC-associated N proteins were phosphorylated at T279. This 
indicates that one seventh of the NC-associated N proteins are phosphorylated when N 
proteins incorporate into the nascent N-RNA complex. Whether N proteins are 
expressed by plasmid or during viral replication (Gombart, et al., 1995), the 
phosphorylation rate of the threonine residue in NC was almost at the same level. Thus, 
T279 phosphorylation of the N protein is required for the maintenance of the 
herringbone-like structure of NC, and is different from the major phosphorylation sites 
that take part in the functional regulation of viral gene expression (Hagiwara, et al., 
2008; Sugai, et al., 2012; Sugai, et al., 2013). Electron microscopy demonstrated that 
NC has a helical structure with approximately 13-14 N proteins per turn (Bhella, et al., 
2004; Kolakofsky, et al., 2005; Bhella, et al., 2002). Therefore, N proteins may change 
its own conformation through the phosphorylation of T279 at a ratio of 1 per 7 to cancel 
the structural distortion of the NC. 
In the present study, the author demonstrated that phosphorylation at T279 is 
a prerequisite for NC formation. However, the relationship between T279 
phosphorylation and conformational changes of NC-associated N proteins remain to be 
clarified. Further analysis of the conformational change in N protein might reveal the 
precise mechanism of NC formation. 
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FIGURE LEGENDS 
 
Fig. 1 
Identification of the minor phosphorylation sites in the N protein by MS analysis. (A) 
Trypsin-digested peptides of N protein were separated by nanoflow-LC and analyzed by 
MALDI-TOF/TOF MS. (B) Phosphorylated peptides from V8 protease-digested N 
proteins were selectively analyzed and identified by MALDI-TOF/TOF MS. The 
analyzed peptides were identified with MASCOT ver. 2.0 database search and are 
shown in red.  
 
Fig. 2 
Analysis of minor phosphorylation sites of N protein. (A) Schematic diagram of the 
alanine substitution mutants of the N protein used in this study. Each phosphorylation 
site is indicated as a green square, and sites substituted with alanine residues are shown 
as a red square with an initial-letter “A”. (B) Identification of the minor phosphorylation 
site in the N protein by immunoprecipitation assay. The N protein or its phosphorylation 
mutants were radio-labeled with 32P or 35S in Cos7 cells. Relative phosphorylation 
(32P-N/35S-N) of each N protein mutant was quantified. (C) Phosphorylation of wt-N 
and the T279A mutant in 293T and Vero cells.  
 
Fig. 3 Phosphorylation analysis of the other serine and threonine residues within N 
protein. (A) Multiple sequence alignment of the N protein CCR (aa 258-357) from 
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Paramyxoviruses: canine distemper virus (GenBank Accession No. AAG30916), 
rinderpest virus (CAA48388), peste des petits ruminants virus (ACN62116), Hendra 
virus (AAC83187), Nipah virus (AAK50548), Sendai virus (AAB06278), mumps virus 
(CBA10117), and human parainfluenza virus type 1 (NP_604433). Black and red 
arrowheads indicate untested S or T residues by MS analysis and putative 
phosphorylation sites detected by MS analysis, respectively. (B) Schematic diagram of 
additional mutants at the CCR, and (C) phosphorylation properties of the mutants. 
 
Fig. 4 
Functional analysis of minor phosphorylation sites. (A) Minigenome assay using 
alanine substitution mutants of the N protein. 293 cells were transfected with 
minigenomic RNA and plasmids for the N, P, and L proteins. On the following day, 
luciferase activity of the cell lysates was measured. (B) Minigenome assay using N 
protein mutants whose T279 site was replaced by acidic residues. 
 
Fig. 5 
Localization and N-P binding ability of T279A mutant. (A) T279 mutants showed 
diffuse cytoplasmic distribution. Cos7 cells were transfected with the plasmid 
expressing the wt-N or T279A mutants, and the localization of each protein was 
detected with anti-N polyclonal antibody. (B) Localization of other N protein mutants, 
and (C) distribution of wt-N and T279A mutant in the presence of the P protein were 
evaluated. (D) The wt-N or T279A mutant was transfected into Cos7 cells, along with 
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the P protein. Proteins were labeled with 35S and co-precipitated with the anti-N 
polyclonal antibody. The bar graph shows the relative quantity of P protein 
coprecipitated with N protein (P protein/N protein). Error bars indicate standard 
deviation. 
 
Fig. 6 
The T279A mutant of the N protein failed to form NC-like particles. (A) Cos7 cells 
were transfected with wt-N or T279A plasmids, and N protein expression levels in cell 
lysates and NC fractions of CsCl density gradient centrifugation are shown. Bar graphs 
indicate the relative expression levels of N protein. Error bars indicate standard 
deviation. (B) Electron microscopy of wt-N and T279A in the NC fraction of CsCl 
density gradient centrifugation. Bar represents 50 nm. 
 
Fig. 7 
The T279A mutant showed the same proteolytic pattern as the wt-N protein. The wt-N, 
T279A, and heat-denatured wt-N proteins were treated with various concentrations of 
trypsin. High contrasted image of the low molecular weight region (<37 kDa) is shown 
for low-density degradation products. Arrowheads indicate the various degradation 
products of the denatured N protein. 
 
Fig. 8 
Dephosphorylation of T279 by BAP treatment impairs NC formation. NC-like particles 
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of the wt-N or N protein mutants were separated by CsCl gradient centrifugation. 
Gradients were divided into 7 fractions, and N protein in each fraction was detected. (A) 
wt-N, (B) T279A, (C) ST10A, (D) ST10A with BAP treatment, and (E) ST10A with 
BAP and phosphatase inhibitor. Bar graphs show the percentage of N protein content in 
each fraction per total N protein in the 7 fractions.  
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 In this study, detailed analyses of phosphorylation sites within measles virus 
N and P proteins were conducted. The author identified some phosphorylation sites, and 
investigated the functions of the phosphorylations.  
In CHAPTER1, the author reported a significant inverse correlation between 
the phosphorylation level of MV-P protein and viral transcriptional activity. 
Upregulation of P protein phosphorylation resulted in reduction of viral transcription. 
Additionally, the author demonstrated that the strong phosphorylation at S86 and S151 
of P protein, which may be generally regulated by association with nucleoprotein, 
downregulates the viral transcriptional activity. Taken together, these findings suggest 
that P protein is involved in the regulation of viral transcription by altering its own 
phosphorylation property. 
In CHAPTER2, to investigate the functional significance of N protein 
phosphorylation, the author rescued recombinant MVs (rMVs) whose phosphorylation 
sites of N protein were substituted with alanine residue (rMV-S479A, rMV-S510A, and 
rMV-S479A/S510A) using a reverse genetics system, and analyses of these 
recombinants were conducted. In the single-step growth experiment, rMVs showed 
more rapid growth kinetics and N protein accumulation than those of wild type MV. It 
has been also demonstrated that the enhancement of viral gene expression was 
accompanied by high levels of cytokine induction. These suggested that 
N-phosphorylation had an important role to control the viral growth rate through 
regulating viral gene expression during the early phase of rMV infection. On the other 
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hand, the multi-step growth curves revealed that N-phosphorylation intensity correlated 
inversely with virus yield. Moreover, excessive N-phosphorylation resulted in the lower 
stability against RNase and the faster turnover of the viral genome RNA. Taken together, 
these results suggest that N-phosphorylation is involved in both the viral gene 
expression and viral genome RNA stability. 
In CHAPTER3, the author identified new phosphorylation site of measles 
virus N protein, and analyzed the function of the phosphorylation. Using mass 
spectrometry, nine putative phosphorylation sites within N protein were identified. The 
author generated alanine substitution mutants for each putative phosphorylation site of 
N protein and examined the phosphorylation signals by 32P labeling. Among these nine 
putative phosphorylation sites, the T279 site was remarkably phosphorylated. The eight 
putative phosphorylation sites other than T279 were not required for N-protein function 
in the minigenome expression assays, but the T279 site was functionally essential. 
Limited proteolysis and electron microscopy showed that a T279A mutant was not 
denatured but lacked the ability for nucleocapsid assembly. Furthermore, 
dephosphorylation treatment of the T279 site by alkaline phosphatase caused 
deficiencies in nucleocapsid formation. Taken together, these results indicate that 
phosphorylation at T279 of N protein is indispensable for functional nucleocapsid 
formation. 
Thus, in this study, the author have demonstrated that the phosphorylation of 
N and P proteins involved in the various steps of viral life cycles such as regulation of 
viral transcriptional activity, viral gene expression level, viral genome stability, and 
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nucleocapsid formation. This is the first report investigating the functions of 
phosphorylation modifications of MV structural proteins using recombinant viruses. 
These findings would shed light on the functional significance of viral protein 
phosphorylation in viral life cycle. 
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論文の内容の要旨 
 
論文題目：Functional Analysis of Phosphorylation Modifications within 
  Measles Virus Nucleoprotein and Phosphoprotein 
(麻疹ウイルスＮ蛋白質及びＰ蛋白質におけるリン酸化修飾の機能解析) 
 
氏名：菅井亮宏 
 
 
麻疹ウイルスの構成蛋白質に対するリン酸化修飾の研究は、１９７０年代後半から始
められており、N 蛋白質や P 蛋白質へのリン酸化修飾が報告されていた。しかしながら、それ
らのリン酸化修飾の機能についての詳細な報告はなく、ウイルス増殖におけるリン酸化修飾の
意義は長らく不明なままであった。また、同じモービリウイルス属に分類されるイヌジステン
パーウイルスや牛疫ウイルス等の、動物に感染するウイルスおいても、構成蛋白質のリン酸化
とその影響については十分に解明されていない。そのため、筆者は、比較的解析が進んでいる
麻疹ウイルスを用いて、N 蛋白質及び P 蛋白質のリン酸化修飾の役割を明らかにするため、詳
細な機能解析を行った。モービリウイルス属のウイルスは、互いに多くの類似した性質を持つ
ことから、本研究で得られた知見は、麻疹ウイルスのみならず、イヌジステンパーウイルスや
牛疫ウイルス等の獣医学的に重要なウイルスにおけるリン酸化修飾について考える上でも有用
であると考えられる。 
 
CHAPTER1 
P 蛋白質リン酸化のウイルス RNA 合成への影響の解析 
 
麻疹ウイルス P 蛋白質はウイルスゲノムの転写及び複製に不可欠な因子であり、N
蛋白質と共にウイルス RNA ゲノムに結合し、ヌクレオカプシドを形成する。N 蛋白質及び P
蛋白質はリン酸化修飾を受けることが知られており、幾つかのウイルスで P 蛋白質のリン酸化
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修飾がウイルスゲノムの転写及び複製効率に影響を及ぼすことが報告されてきたが、麻疹ウイ
ルスの P 蛋白質に関する報告はなかった。一方で、近年、当研究室では N 蛋白質のリン酸化修
飾が、ウイルスゲノムの転写及び複製の効率に影響を与えることを報告した。そこで、本研究
では、N 蛋白質及び P 蛋白質のリン酸化修飾とウイルスゲノムの転写複製効率の関連性につい
て解析した。 
ウイルスゲノムの転写複製と N 及び P 蛋白質のリン酸化状態との関連性を調べるた
め、N 蛋白質のリン酸化部位変異体（S479A、S510A、S479A/S510A）と P 蛋白質を、L 蛋白
質及びミニゲノム RNA と共に培養細胞内で共発現し 32P 標識して、N 及び P 蛋白質のリン酸化
状態を解析した。また、ミニゲノムレポーターアッセイにより転写複製活性を測定し、N 及び P
蛋白質のリン酸化状態との関連性を調べた。P 蛋白質のリン酸化部位変異体（S86A/S151A、
T49A/S86A/S151A）を用い、N 及び P 蛋白質のリン酸化状態を解析し、転写複製活性への影響
を評価した。また、転写と複製のどちらが影響を受けるのか調べるため、定量 PCR によりミニ
ゲノム RNA の転写複製産物の量を測定した。 
これらの解析の結果、N-P 蛋白質間相互作用により、N 蛋白質のリン酸化状態の変化
が、P 蛋白質のリン酸化状態に影響を与えることが示唆された。この N 蛋白質のリン酸化状態
の変化によって影響を受ける部位は、P 蛋白質の８６及び１５１番目のセリン残基であり、これ
らの部位へのリン酸化がウイルス RNA 合成を著しく阻害することが明らかとなった。また、N
蛋白質リン酸化率とウイルスゲノムの転写及び複製効率に相関性は見られなかったが、P 蛋白質
リン酸化率がウイルス RNA 転写及び複製量と逆相関することが示された。定量 PCR の結果か
ら、S86 及び S151 のリン酸化は、ウイルス RNAの転写を選択的に抑制することが示唆された。 
以上の結果から、N 蛋白質のリン酸化状態はウイルスゲノムの転写及び複製効率に直
接的にではなく、P 蛋白質のリン酸化状態を変化させることにより間接的に作用するものと考え
られた。P 蛋白質の S86 及び S151 のリン酸化状態が高いほど転写及び複製効率が低下するとい
う逆相関関係が見られ、S86 及び S151 へのリン酸化は P 蛋白質の活性には必要とされないが、
これらのサイトへのリン酸化がウイルス RNA 転写の下方調節に働く可能性が示唆された。 
 
CHAPTER2 
組換え麻疹ウイルスによる N 蛋白質リン酸化の機能解析 
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麻疹ウイルスにおける N 蛋白質の主要な役割の一つは、ウイルスＲＮＡゲノムを物
理的に被覆し保護することである。近年、当研究室では、N 蛋白質のリン酸化部位の解析を行
い、主要な２箇所のリン酸化部位を同定し、このリン酸化修飾がミニゲノム系においてウイル
スゲノムの転写及び複製の効率に影響を与えることを報告した。しかしながら、それらのリン
酸化修飾が実際のウイルス増殖に与える影響は不明であった。今回、筆者はリバースジェネテ
ィクス法によって N 蛋白質のリン酸化部位を変異させた組換えウイルスを作出し、リン酸化修
飾がウイルスの増殖効率等に与える影響を解析した。 
各リン酸化部位に変異を導入した組換えウイルスの力価を測定し、増殖曲線を作製し
た。同時に、各組換えウイルスの遺伝子発現活性を比較する為、感染細胞内の N 蛋白質量を経
時的に測定した。続いて、パルスチェイスアッセイ及びヌクレアーゼ耐性試験により、N 蛋白
質のリン酸化状態とウイルスゲノムの安定性の関連を評価した。 
各組換えウイルスの解析により、増殖初期には野生型に比べ変異ウイルスの遺伝子発
現及び増殖が上昇することが明らかとなった。また、このウイルス増殖の上昇に伴い、著しい
サイトカインの誘導が見られた。一方、増殖がプラトーに達すると N 蛋白質のリン酸化状態が
低いほど増殖が高いという逆相関関係が見られた。また、N 蛋白質のリン酸化率が低いほどウ
イルスゲノムのヌクレアーゼ耐性が増強し、安定化することが明らかとなった。 
増殖初期において、リン酸化部位変異ウイルスでＮ遺伝子発現上昇が見られたことか
ら、リン酸化が何らかの機構でウイルス遺伝子の発現調節に関わる可能性が示唆された。また、
増殖後期における N 蛋白質のリン酸化レベルとウイルス増殖の逆相関は、リン酸基とウイルス
ゲノムの電荷的反発によるゲノムの不安定化を介したものであることが推察された。更に、P 蛋
白質が N 蛋白質に結合することで、N 蛋白質のリン酸化状態の低下を引き起こし、このことが
ヌクレオカプシド形成の効率化に寄与していることが示唆された。 
 
CHAPTER3 
新しく同定された N 蛋白質のリン酸化部位とその役割 
 
麻疹ウイルスのN蛋白質はウイルスゲノムRNAに結合してヌクレオカプシドを形成
し、これが足場となってウイルスゲノムの転写及び複製が行われる。これまで筆者は、N 蛋白
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質の主要な二カ所のリン酸化部位について、ウイルス増殖における役割を解析してきたが、こ
れら二カ所以外にもリン酸化部位の存在が示唆されていた。本研究では、筆者は N 蛋白質の新
たなリン酸化部位を同定し、その役割を明らかにするため、機能解析を行った。 
MS 解析（質量分析法）により推定リン酸化部位を絞り込み、アラニンスキャン及び
32P ラベルによってリン酸化部位を同定した。リン酸化部位を変異させた N 蛋白質を作製し、ミ
ニゲノムアッセイによりウイルスの転写及び複製への影響を評価した。更に、P 蛋白質との相互
作用への影響を共沈実験により確認した。また、電子顕微鏡による解析、密度勾配遠心法、脱
リン酸化酵素を用いた解析により、リン酸化とヌクレオカプシド形成の関連性を検索した。 
MS 解析の結果、リン酸化部位の候補が九カ所見つかり、アラニン置換変異体を用い
た解析で、279 番目のスレオニン残基がリン酸化されていることが明らかとなった。このリン酸
化部位を変異させると、N 蛋白質と P 蛋白質の相互作用には影響しなかったが、ミニゲノムア
ッセイにおいて転写及び複製の活性が著しく損なわれた。更に、電子顕微鏡を用いた解析にお
いて、このスレオニン残基のアラニン置換変異体はヌクレオカプシドを形成できず、異常な構
造体が観察された。また、このリン酸化部位の脱リン酸化処理によって、ヌクレオカプシドの
構造が不安定化することが示唆された。 
N 蛋白質 279 番目のスレオニン残基のリン酸化修飾は、正常なヌクレオカプシド構
造の形成に不可欠であることが明らかとなった。このリン酸化修飾は、ウイルスゲノムの転写
及び複製に必須であり、ウイルスが増殖する上で非常に重要な役割を担っていると考えられる。 
 
結び 
 
本研究において、筆者は N 蛋白質及び P 蛋白質のリン酸化修飾が、それぞれの機能
に及ぼす影響について、リン酸化部位変異体や組換えウイルスを用いることで詳細に解析して
きた。その結果、P 蛋白質のリン酸化はウイルス RNA の転写制御に関与することが示唆され、
N 蛋白質のリン酸化はウイルス構成蛋白質の発現量、ウイルスゲノム RNA の安定性に影響を及
ぼすことが示された。また、新規に同定された N 蛋白質の N 末端側のリン酸化修飾は、ヌクレ
オカプシドの形成に必須であることが明らかとなった。本研究は、麻疹ウイルス構成蛋白質に
対するリン酸化修飾の機能について、組換えウイルスを用いて詳細に解析を行った初めての報
告であり、リン酸化修飾が持つ生物学的意義について考察する上で重要な多くの新しい知見が
示された。ここで得られた知見は、麻疹ウイルスに限らず、近縁のイヌジステンパーウイルス
や牛疫ウイルスといった獣医学領域で重要なウイルスを含め、広くパラミクソウイルス全般に
有用な知見を与えると考えられる。 
